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The Enhancement and Enrichment of Skeletal Stem Cells and
Impaction Bone Graft for Orthopaedic Application
Andrew M H Jones
With  an ageing population putting  ever  increasing  demands  on  the
musculoskeletal  system  there  is  a  growing  need  for the development  of
regenerative  medical strategies  to  provide  for  the  healthcare  needs  of  the
future. With increasing numbers of joint arthroplasty occurring in younger and
younger patients there is likely to be a growing need for therapeutic strategies
to replace lost bone stock in the coming decades
This  thesis  aims  to  explore  strategies  to  enhance  the  biological  and
mechanical  properties  of  impaction  bone  grafting  and  the  effects  of  skeletal
stem cell (SSC) concentration. In order for SSC to be effective in replacing new
bone stock new strategies looking to enhance osteogenic differentiation have
been examined.
Section I: An in vitro Impaction Bone Graft (IBG) model of SSC seeded onto
human allograft was used to study the biomechanical effects of altering SSC
concentration. The use of concentrated SSC was then used in the treatment of
patients with avascular necrosis (AVN) of the femoral head and fracture non
union with parallel in vitro analysis of the samples.4
Section II: In vitro and murine in vivo analysis of the biomechanical effects of
type  1  Collagen  and  Hydroxyapatite  nanoparticles  primarily  looking  at
differences in shear strength and osteogenic differentiation compared to plain
allograft and basal cultured SSC.
Section III: An in  vitro  acetabular model  was  used  to  study  the  effect  of
vibration  IBG  compared  to  standard  techniques  in  revision  hip  surgery.  The
graft compaction, force of impaction, fracture risk and rate of subsidence post
cyclical loading was assessed.
This thesis has demonstrated in vitro and in vivo strategies that are clinically
translatable and have demonstrated that:
 Skeletal  Stem  Cell  concentration  plays  a  pivotal  role  in  the
biomechanical enhancement of Impacted bone graft (IBG)
 Translation  of  these  strategies  into  the  successful  treatment  of
fracture non union and Avascular necrosis of the hip.
 Type 1 Collagen and Hydroxyapatite nanoparticles both enhance
the osteogenic differentiation and shear strength of the IBG / SSC
construct
 Vibration  impaction  bone  grafting  is a  novel  technique  that
significantly reduces the intraoperative risk of acetabular fracture
or catastrophic subsidence
This  thesis  has  demonstrated  novel  techniques  for  the  biomechanical
enhancement of IBG with most techniques being readily transferable to clinical
practice with the potential to form part of a surgeon’s armament for regenerative
medical techniques of the future.5
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Chapter 1
Introduction
1:1 Burden of the Problem
The requirement to reconstruct bone defects presents an increasing burden to
healthcare in the face of the demographic challenges of an increasing aged
population. The proportion of people in Britain aged over 65 years is estimated
to increase by 50% in the next 25 years (ONS 2008). A concomitant increase
in surgery for orthopaedic complications can be expected, which emphasizes
the need for innovative approaches to skeletal reconstruction.
While traditional causes of bone loss such as trauma, infection and tumours
present ongoing challenges, there is now a growing cohort of patients who
require  bone  defect  reconstruction  during  revision  arthroplasty  surgery.  In
2008  in  England  and  Wales,  there  were  approximately  65,000  primary  hip
replacements performed in comparison to just 30,000 in 2003, and the number
of  revision  hip  procedures  doubled  over  this  period,  to  6,600 (NJR  2009).
Given  these  demographic  changes  and  that  joint  replacements  are  being
increasingly  performed  in  younger  patients,  the  number  of  people  outliving
their prosthesis can be projected to increase. Patients now present in rapidly
increasing  numbers,  often  with  extensive  bone  loss  around  loose  implants,
which  poses  a  substantial  orthopaedic  challenge  for  revision  surgery.  In
addition,  knee  arthroplasty  is  now  performed  more  frequently  than  hip30
arthroplasty (NJR 2009), thus the true scale of the problem of inadequate bone
stock in revising total knee replacements will only emerge in years to come.
Fig  1:1  Radiograph  of  a  failing  left  total  hip  replacement.  Dashed  line  signifying  the
extent  of  acetabular  bone  loss  with  a  large  cavity  formed  by  the  loose  component.
(Courtesy of the Royal Berkshire Hospital)
Furthermore,  the  patient  of  today  has  higher  expectations  of  medical
intervention (Nilsdotter, Toksvig-Larsen et al. 2009) and a deteriorating, painful
prosthetic  joint  will  often  be  poorly  tolerated  in  the  context  of  bone  loss
occurring as a result of a previous therapeutic intervention.
1:2 Impaction Bone Grafting
Impaction bone grafting (IBG) using fresh frozen morselised allograft remains
the current gold standard for replacing bone stock encountered during revision
hip surgery and has been used as a void filler as such for forty years (Slooff,
Huiskes et al. 1984). The technique, which employs fresh frozen morselised
allograft  as  a  passive  ‘void  filler’,  endeavours  to  recreate  a  solid,  adaptive31
mantle into which the implant can sit securely, immediately withstanding forces
associated with normal implant use.
IBG for the acetabulum was first introduced by Slooff et al in Nijmegen in the
late  1970s (Slooff,  Huiskes  et  al.  1984)  with  Ling and  the  Exeter  group
describing the technique for Femoral IBG (Ling, Gie et al 1993). The technique
for acetabular IBG is shown in Fig 1:1.
Fig 1:2 Schematic diagram showing the key steps in IBG of the acetabulum.
A: Acetabular defect with cavities. B: Bridging of defects with mesh. C,D: Impaction of
Bone Graft chips with tamp. E: Final impacted bed. F: Cement pressurisation into bed.
G:  Implantation  of  Acetabular  cup  into  cement  base.  Adapted  from Schreurs  BW,
Gardeniers JW, Slooff TJ: Acetabular reconstruction with bone impaction grafting: 20
years of experience. Instr Course Lect 2001;50:221-228.
It involves firstly creating a contained defect, for which a metal mesh or large
allograft blocks can be used to cover any defects in the cavity wall.  Multiple
superficial drill holes can be made in the bone to help initiate vascular invasion
at this stage. The graft bed is then built up in a step wise fashion with small32
amounts of allograft added and impacted before adding further graft. Once the
cavitatory defect has been filled sufficiently with compacted allograft cement is
then pressurised into the cavity in a relatively viscous state and an appropriate
cup (2-4mm smaller than the last tamp diameter) is implanted. (Adapted from
Exeter Xchange revision acetabular surgical protocol)
Survivorship  for  acetabular  and  femoral  components  at  20  and  10  years
respectively is encouraging (87% and 99%) although such results have not
always been repeated outside specialist centres (Eldridge, Smith et al. 1997;
van Haaren, Heyligers et al. 2007). van Haaren and colleagues from Nijmegen
reviewed 71 Cases of Acetabular revisions with IBG and found a survival rate
of 72% (95% CI, 54.4 to 80.5) at 7 years for aseptic loosening. The majority of
failures  occurring in  those  with  severe  defects  with  poor  graft  incorporation
being the main cause  (van Haaren, Heyligers et al. 2007). A recent review of
61 cases by Schreurs et al has shown an overall survival rate at 20  years of
79% although once revision for other causes are excluded, the revision rate for
asceptic loosening is 87% (Schreurs et al 2009). So whilst the revision rate for
what can be significant bone loss is encouraging, there is clearly potential to
improve this technique and the survivorship further.
The ability of the graft bed to resist the forces placed upon it and form a new
living bony construct is a critical factor for the long-term success of the revision
implant. However, histological specimens from acetabular IBG reveal fibrous
and necrotic tissue amongst areas of graft integration (van der Donk, Buma et
al. 2002; van Haaren, Heyligers et al. 2007). The process of replacing and33
remodelling of the IBG bed occurs by creeping substitution (Burchardt, Hans
1983)  and  therefore  as  the  depth  of  bed  increases  so  the  risk  of  central
necrotic areas increases as the distance from the host blood supply increases.
Weidenheilm  et  al  (Weidenheilm  L.R  et  al  2001)  performed  histological
analysis of retrieved IBG samples and described three main zones of the graft
bed. There was a central / inner zone that contained both the bone cement but
also  areas  of  necrotic  graft  and  trabeculae  along  with  some  vascularised
fiborous  tissue.  The  middle  zone  contained  viable  trabecular  bone  with  an
incomplete  peripheral  cortex.  The  final  outer  zone  was  made  up  of  viable
cortex. Whilst this composite histological structure of the IBG does appear to
offer good structural support for the majority of cases, there is clearly potential
for  the  necrotic  areas  to  collapse.  The  majority  of  cases  of  failure  in  van
Haaren et al’s study were those with severe defects, and it may be the case
that once the graft bed exceeds a certain depth, tissue necrosis in the ‘inner’
zone becomes inevitable (van Haaren, Heyligers et al. 2007).
The application of tissue engineering strategies to promote the generation of
host bone, and thereby improve the biomechanical characteristics of the graft,
has potential to improve the outcomes of this demanding technique. Recent
work within our laboratory, and also by others, has identified mechanical and
biological  factors  that  can  be  modulated  to  augment  the  structure  and
performance of IBG (Shetty, Slack et al. 2005; Bolland, Partridge et al. 2006;
Bolland, Tilley et al. 2007). Factors, such as preparation of graft, constituent
particle size, cellular composition, chemical additions and local fluid drainage
have all been shown to affect the performance of IBG (Dunlop, Brewster et al.34
2003; Bolland, New et al. 2008; Jones AMH et al 2009). Whilst skeletal stem
cells (SSCs) in themselves have been shown to augment the biological and
mechanical  properties  of  impaction  bone  grafting (Bolland,  Partridge  et  al.
2006).
1:3 Allograft
Allograft is usually obtained from consenting patients undergoing primary total
hip  replacement  but  also  from  consented  cadaveric  retrieval.  The different
techniques of processing and storage of the allograft prior to use has been
studied extensively. The main three options being fresh frozen, freeze dried
and  irradiated  allograft.  All  have  advantages  and  disadvantages  with  a
compromise between prevention of potential disease transmission (Simonds et
al.,  1992;  Lord  et  al.,  1988;  Buck  et  al.,  1989),  immunogenic  response
(Eldridge  et  al.,  1997) and  disruption  of  the  mechanical  and  osteoinductive
properties of the graft (Schreurs et al  2004). Irradiation of the graft, whilst
reducing  the  risk  of  disease  transmission  has  been  shown  to  have  inferior
mechanical properties with reduced graft incorporation (Delloye C et al 2007;
Hannink G et al 2007) although this is debated and there is evidence to the
contrary (Hannik G et al 2007). In a clinical study on acetabular IBG Ochs BG
et al showed that the results of combining irradiated graft and Bone marrow
aspirate were comparable to plain fresh frozen allograft at 3 years follow up
(Ochs  et  al  2010). Their  study  of  79  acetabular  reconstructions  showed
comparable Harris hip scores at final follow up, and 100% incorporation of the
graft beds as demonstrated by trabeculation on plain radiographs. There were35
no signs of acetabular loosening at final follow up, although it should be noted
that all reconstructions were with the use of a reinforcement ring in addition to
the IBG and therefore the mechanical demands of the IBG construct were not
as great as an IBG alone.
Fresh  frozen  allograft  has  the  advantage  of  retaining  some  of  the
osteoinductive  properties  but  does  carry increased  risk  of  an  immunogenic
response. In order to reduce this response the mechanical effects of pulse
lavage washing and de-fatting of the samples prior to IBG has been studied
(Dunlop  DG,  Brewster   et  al 2003).  This  demonstrated  that  there  was  a
significant mechanical advantage to washing of the allograft with further benefit
from de-fatting with Hydrogen Peroxide.
The grading of the allograft particles has also been shown to be a critical factor
(Dunlop et al 2003). The key of any impacted aggregate is to allow a tight
inter-digitation between the particles to prevent any movement under shear. In
order for this to be optimised the aggregate needs to be ‘well graded’ i.e it is
beneficial to be made up of particles of multiple different sizes. This allows the
larger particles to form the main basis of the aggregate to provide structural
support, but the smaller particles can fill the voids and lead to a more densely
packed aggregate (Smith GN 1990) See Fig 1:2.
Calculation of the shear strength of an aggregate such as IBG is done using
the Mohr Coulumb Failure Law, the process of which is discussed in more
detail in section 2:5.36
Fig  1:3  Schematic  representation  of  impacted  allograft  particles  demonstrating  the
importance of multiple particle sizes to allow dense packing of the graft and filling of
any voids
The optimal graft characteristics would include Osteoconductive (the ability to
provide  structure  for  the  attachment  and  growth  of  cells),  Osteoinductive
(contain  active  factors  to  stimulate  cell  migration  and  differentiation)  and
Osteogenic  (contain  cells  from  the  osteogenic  lineage)_properties. Fresh
autollogous graft has all three of these properties, in the context of IBG, the
volumes  of  graft  required  are  not  available  and  would  cause  significant
morbidity. Fresh  Frozen Allograft  has been  shown  to have  osteoconductive
and some osteinductive properties due to the retained osteoinductive agents
(Bormann et al 2010). The osteoinductive effect is however very small and this
is further diminished by repeated washing of the allograft (Dunlop 2003).. For
new  bone  formation  another  critical  factor  is  that  of  vascular in  growth  or
angiogenesis. In order for these new vessels to form and survive requires a37
high  level  of  stability  within  the  graft  bed  as  any  shear  can  disrupt  their
formation remodelling (Hernigou et al. 2005 ;Stevenson et al 1996).
Other factors affecting the use of allograft are the supply and storage of the
graft. Introduction of the Human Tissue act in the UK in 1984 has ensured
traceability and control of the storage of all allograft samples used, to allow any
tracking of potential disease transmission. The storage of the allograft is also
required  to  be  in  a  licensed  facility  which  has  meant  the  majority  of  UK
Hospitals no longer have an in-house ‘bone bank’ with femoral heads having to
be ordered in for individual cases. This has led to significant logistical issues
for hospitals wishing to use it which puts further burden on a stretched NHS
service.  There has also been concern raised that the potential demand for
allograft could outstrip supply given the predicted rise in revision arthroplasty
(Delloye et al 2007). Further work has therefore shifted to look at potential
synthetic  scaffolds  that  can  act  as  either  supplements  or  replacements  for
fresh frozen allograft.
1:4 Bone Graft Extenders
To counter some of the issues described above regarding allograft a variety of
synthetic scaffolds have been proposed and studies both as additives to the
allograft and on their own. Early studies (Brewster et al 1999) looked at the
effects  of  addition of an  inert  bioglass  compound  and  showed  that  these
increased the shear strength of the IBG construct, possibly due to improving
the  grading  (mix  of  particle  sizes)  of  the  compound.  Hydroxyapatite  and
tricalcium phosphate (TCP) ceramics have also been used as extenders and
have shown osseointegration (Ransford A et al 1998). There have however38
been some concerns raised about their ability to maintain a stable structure
under loads (Hanft J et al 1995).
‘Bonesave’ (Stryker, Howmedica)  a compound made of 80% TCP and 20%
HA has been shown to be an effective bone graft extender with good results in
a sheep model at up to 90% extender : 10% Allograft mix in a sheep IBG
model (Blom AW et al 2005) with similar fusion rates found in a clinical study
on spinal fusion using Bonesave (Kapur RA et al 2010) .
Fig 1:4 Bonesave granules used as bonegraft extender. (Stryker Howmedica)
Polymeric scaffolds have attracted interest in the field of tissue engineering
due  to  their  inert  nature,  and  ability  to  modify  the  structural  shape
comparatively easily. An example of these scaffolds are Polylactic acid (PLA)
and  Polyglycolic  acid  (PLG)  which  are  manufactured  using  high  pressure
carbon  dioxide  that  can  be  modulated  to  affect  porosity  and  composition
(Kanczler  et  al  2008).  These  have  been  shown  to  offer  similar  mechanical
properties  under  shear,  but  are  also  biocompatible  and  support  the
proliferation of HBMSC (Bolland et al 2008). A further advantage of some of
the  bone  graft  extenders  is  the  ability  to  incorporate  other  factors  such  as
growth factors into the structure to change them from merely osteoconductive
to osteoinductive and to control SSC differentiation and potential angiogenesis
(Kanczler et al 2008 & 2010).39
1:5 Bone Graft additives
The  process  of  Bone  formation  and  remodelling  is  a  highly  complicated
synergistic process involving the fine balance of Osteoclastic resorption and
Osteoblastic  bone  formation. New  bone  formation  is  dependant  upon  an
adequate blood supply to deliver nutrients, oxygen and precursor cells to the
tissue, and so the use of factors controlling the formation of new blood vessels
may be useful. Kanczler et al has shown that the use of Vascular Endothelial
Growth Factor (VEGF) can be incorporated into scaffolds and cause enhanced
vessel  and  new  bone  formation  (Kanczler  et  al 2010).  Bone  Morphogenic
Proteins (BMP) have also been used to try and stimulate new bone formation.
They are multifactorial growth factors that belong in the Transforming Growth
Factor β (TGF-β) superfamily. The activity of BMP was first identified in the
1960s  (Urist  et  al  1965)  with  the  proteins  responsible  for  bone  formation
described  by  Wozney  et  al  1988  amongst  others. BMP-7  (also  known  as
osteogenic  protein-1  /  OP-1) and  BMP-2  both  play  a  key  role  in  the
differentiation of SSC into bone and cartilage and have been used in a number
of studies and clinical applications (Ristiniemi et al 2007; .Vaidya R et al 2007).
Their function is not purely on enhancing osteogenic differentiation however,
and there is also stimulation of Osteoclast activity which in some studies may
account for problems of subsidence due to increased osteoclast led resorption
(McGee et al 2004). McGee’s study was a sheep IBG hemiarthroplasty model
with  6  control  plain  IBG  and  6  sheep  with  an  IBG  OP-1  mix  (OP-1
concentration ranged from 60 to 89 pg OP-l per 1g of bone). Analysis of the
samples  was  carried  out  at  6,  18  and  26  weeks  with  2  from  each  group
sacrificed at each time point. Mc Gee reported improved graft incorporation40
and remodelling in the OP-1 group, but with that, evidence of accelerated bone
resorption compared  to  plain  allograft  with  corresponding  femoral  stem
subsidence in one of the OP-1 group at six weeks. These results should be
interpreted with caution however as it is only a small pilot study and further
work on the optimal dosing of OP-1 in the IBG setting is required.
More recently the use of Platelet Rich Plasma (PRP) has been gaining a lot of
media attention as a potential cure for joint and tissue damage. As yet there
are  no  large  scale  clinical  trials,  although  results  from  some  studies  are
encouraging,  there  remains  significant  scepticism  as  to  the  true  benefit
(Alsousou et al 2009; Moran et al 2010). The underlying rationale for its use is
that it contains a multitude of concentrated growth factors such as VEGF, TGF-
β, Platelet Derived Growth Factor and Interleukins which can in theory all work
in a synergistic fashion to induce tissue repair.
1:6 Skeletal Stem Cells
A stem cell is a cell that has the ability to self renew, differentiate into a number
of  different  cell  types  and  to  maintain  the  ability  to  divide  and  replicate
throughout its life. A wide variety of names have been given to the cell which
for the purpose of this study will be termed Skeletal Stem Cell (SSC) (Bianco
and Robey 2001). Other names given have been bone marrow stromal cells,
Mesenchymal stem cells (Goshima et al. 1991) and marrow stromal fibroblastic
cells (Triffitt et al  2002).41
Most Stem cells can be isolated by their cell surface markers, but whilst the
surface  markers  for  most  haemopoetic  stem  cells  are  clearly  defined,  the
specific surface markers for SSC are not. There are a number of markers that
can be used to narrow down the SSC yield of a sample, but none are exclusive
or specific to SSC alone (e.g they are negative for some haemopoetic markers
CD34,  CD45,  CD14,  and  positive  for Stro-1,  CD29,  CD  73,  CD90,  CD105,
CD166  and  CD44)  (Dominici et  al  2006;  Abdallah et  al  2005;  Foster  et  al
2005). The most commonly used antibody for SSC isolation is the STRO-1
antibody for a trypsin resistant surface marker found on most cells within CFU-
F colonies (Simmons et al 1991; Deschaseaux et al 2003; Stewart et al 2003).
Prospective isolation of true SSC can therefore be problematic, traditionally
their propensity to adhere to tissue culture plastic compared to haemopoetic
cells can be used to isolate by monolayer culture however analysis of the CFU-
F cells has shown that only around 30% are multipotent and therefore true
SSC (Grothos et al 2003).
Multipotent  skeletal  stem  cells  (SSCs)  present  in  bone  marrow,  have  the
potential  to  differentiate  down  a  number  of  different  cell  lineages  including
osteoblasts, chondrocytes, fibroblasts and adipocytes (Fig 1:2).42
Fig  1:4  Schematic  diagram  showing  the  mesenchymal  lineage  with  differentiation  of
SSC to their differentiated progeny. (Adapted from Oreffo, Cooper et al 2005)
In IBG it is desirable to maximise the differentiation of these stem cells to form
bone and thus a solid osseous construct, rather than fibrous tissue. Whilst it is
straightforward to encourage differentiation into the osteogenic lineage in vitro
by  modulation  of  growth  conditions  and  media  constituents,  many  of  these
methods (e.g. the addition of dexamethasone, or the creation of a hypocapnic
environment) are not transferable to clinical practice due to local and systemic
side  effects.  However  there  is  potential  to  use  non-toxic  factors in  vivo  to
enhance  cellular  adhesion  and  encourage  proliferation  down  an  osteogenic
lineage, resulting in improved mechanical and biological properties of the IBG
composite.(Baas et al 2008).43
In vitro work has shown that SSCs combined with allograft can not only survive
the  impaction  process  and  continue  to  proliferate,  but  also  improve  the
mechanical (shear) characteristics of the construct (Bolland et al. 2006). In vivo
(murine) studies have reinforced these findings and also show enhanced new
vessel  formation  within  the  constructs (Kanczler  et  al.  2010),  raising  the
possibility of de novo bone formation and potentiation within the graft tissue.
The  accepted  method  for  replacement  of  allograft  in  IBG  is  via  creeping
substitution; however the concept of a living graft which becomes incorporated
into, rather than replaced by the surrounding host tissue presents a paradigm
shift  to  the  concept  of  allograft  use.  This  would  bring  the  advantages  of
autograft to the application of allograft, whilst avoiding any inherent donor site
morbidity.4445
Chapter 2
Materials & Methods
2:1 Allograft
Fresh femoral heads, which are normally discarded after total hip replacement
surgery were retrieved from patients after appropriate consent and local ethics
committee approval. These were then stored at -80
oC for over 6 months before
processing.  Under aseptic  conditions,  in  the  operating  theatre  the  femoral
heads were defrosted with warm saline. The soft tissue, articular cartilage and
any osteophytes were removed from the femoral heads. Thick cortical bone
was also removed using nibblers and an oscillating saw. The heads were then
divided in two and placed into the bone mill. Previous studies have looked at a
number of surgical bone mills (Dunlop, Brewster et al. 2003) and the Aesculap
3mm bone mill was found to give the optimum bone graft chip size with a well
graded mixture. The milled allograft was placed in a jug and submersed in a
solution of 6% Hydrogen peroxide for 10 minutes which acted as a de-fatting
process.  The  layer  of  fat  was  decanted  from  the  top  of  the  jug  and  the
remaining  H2O2  poured  out.  The  allograft  was  then  subjected  to repeat
washing with pulsed lavage saline until the solution ran clear. Any further soft
tissue or cortical bone noted at this stage was also removed.
Fig 2:1 Aesculap Bone mill with morcellised graft prior to washing and de fatting. Scale
5cm. Photo courtesy of Aarvold A.46
The allograft was then soaked in an antibiotic / antimycotic solution for 24Hrs
before further washing in a phosphate buffer solution. The graft was then dried
prior to use.
2:2 Tissue culture
Cell Culture / Histology / Biochemistry
All cell based laborotary work was carried out with the assistance of the Bone
and Joint Research group, with well established protocols for the majority of
the  steps  outlined  in  this  project. The  IBG  impaction  and  cell  culture  and
mechanical  testing  were  performed  using  techniques  and  materials  as
previously described by Mr S Tilley, Mr B Bolland and Dr A New. Summary of
the main methods is as follows:
2:2:1 Human bone marrow stromal cell culture
As with the collection of femoral heads, bone marrow samples were collected
from haematologically normal patients undergoing total hip replacements after
appropriate consent and local ethics committee approval. In a 50ml falcon tube
the bone marrow samples were repeatedly washed with α-MEM and agitated
to displace any cells from within the small bone marrow chips. The solution
was then passed through a 70μm filter to collect any further bone or soft tissue
debris. The falcon tubes were then centrifuged at 1100rpm for 5 min at 4
oC.
The supernant  was  discarded  and  the  cell  pellet  resuspended  in 10mls  α-
MEM. The sample cell count was determined via a standard haemocytometer
with  the  red  blood  cells  lysed  with  a  1:1  solution  of  0.1%  acetic  acid.  The
samples  were  then  transferred  to  tissue  culture  flasks  (number  and  size
dependant on the sample yield) and cultured in α-MEM and 10% FCS under
either  basal  or osteogenic  conditions  (100uM  ascorbate-2-phosphate,  and
10nM dexamethasone) depending on the experimental run, and incubated at
37
oC in 5% CO2. The first wash in PBS and media change occurred at day 6
and then was repeated every 3-4 days.47
2:2:2 Cell passage
Upon reaching confluence, the cells were incubated for 10mins with a 10%
Trypsin-EDTA solution in PBS. This caused the cells to release from the tissue
culture plastic flask. For those cells cultured under osteogenic conditions, a
further step of addition of Collagenase was added first in order to break down
the  extracellular  matrix  prior  to  Trypsinisation  and  prevent  clumping  of  the
cells. α-MEM was added to the lysate to terminate the effect of Trypsin. The
cell suspension was centrifuged at 1200rpm for 5 minutes at 4
oC producing a
cell pellet. The solution of Trypsin and α-MEM was removed from the pellet
and the cells were then resuspended in fresh α-MEM media (containing 10%
serum) and either plated to culture flasks or seeded onto scaffolds depending
on the experimental run.
2:2:3 Cell seeding & agitation
Cell count was performed using a standard haemocytometer. The volume of
suspension required for the desired number of cells was calculated. The set
quantity of allograft was contained in loose chip form within a falcon tube and
the cell suspension was then added over the allograft in a drip wise fashion
ensuring equal spread over the graft. Further plain media was then added to
ensure  complete  graft  coverage.  The  seeded allograft  contained  within the
Falcon was then placed on an agitator (Belly dancer) within the incubator for 1
hour to allow the cells to mix freely with the allograft and adhere to the scaffold
prior to impaction. Only P1 cultured cells were used in all studies.
2:2:4 Cell viability
Cell  viability  following  impaction  and  culture  was  determined  by  using  the
fluorescent probes Cell tracker Green
TM CMFDA (10μg/ml) for live cells and
Ethidium  Homodimer-1  (5μg/ml),  (CTG/EH-1)  for  dead  /  necrotic  cells. The
cells were initially bathed in α-MEM containing CTG/EH-1 at 37
0C for 1 hour.
Samples were then washed twice with α-MEM, bathed for a further 45 minutes
(in  α-MEM  only) and repeat  rinsed  in  PBS  before  fixing  in  4%
paraformaldehyde  for  12  hours.  Samples  were  immersed  in  PBS  and
visualised with appropriate fluorescent filters.48
Images were captured and processed with Carl Zeiss Axiovision software Ver
3.0 via an AxioCam HR digital camera on an Axiovert 200 inverted microscope
(Carl Zeiss AG, Germany).
Fig 2:2 Fluorescent microscopy image of human allograft sample (baseline green
colour) covered in CTG stained live SSC (vertical green arrows) and necrotic dead cells
fluorescing red (horizontal red arrows). Scale Bar 100μm
2:3 Biochemical analysis
2:3:1 Alkaline phosphatase activity
Alkaline  Phosphatase  (ALP)  enzme  activity  can  be  used  as  a  marker  for
Osteogenic differentiation of SSC as it is expressed by osteoblasts during the
early phase of bone formation. For this study the following assay was used to
quantify the level of ALP activity.
Trypsin / EDTA (0.05%) was used to cover the samples and incubated at 37
oC
and  5%  CO2 for  approximately  30  minutes  with the  samples vigorously
vortexed twice during incubation. The solution was removed and cells were
collected  by  centrifugation  at  13,000rpm  for  10  minutes  at  4
oC,  and  then
resuspended  in  1ml  0.05%  Triton  X-100. Cell  wall Lysis  was  achieved  by
multiple freeze–thawing (>x3) and samples were stored at -20
oC until assayed.
10ul  of  cell  lysate  from  each  sample  was  used  to  quantify  alkaline
phosphatase activity. Cell solutions were incubated at room temperature with
90ul  of  2-amino-2-methyl-1-propanol  buffer  containing  100mM  p-49
nitrophenolphosphate (pNPP). The reaction was timed and stopped with 100ul
of  1M  sodium  hydroxide  (NaOH). Each  sample  was  measured  in  triplicate
against  two  standards. The  turnover  of  pNPP,  used  to  quantify  alkaline
phosphatase activity, was measured by the absorbance values at 410nm on a
Bio-Tek KC4 Kineticalc microplate fluorescent reader. Results were expressed
as nM pNPP/ng DNA/hr.
2:3:2 Pico Green  DNA quantification assay
Measurement  of  DNA  concentration  was  assayed  with  PicoGreen®  dsDNA
quantification reagent which is an ultrasensitive fluorescent nucleic acid stain
that allows accurate detection of even small quantities of DNA. 10ul of cell
lysate samples as described in 2:3:1 were loaded with 90ul Tris-EDTA (Tris-
HCL Ethylenediamine Tetra-acetic acid) buffer and 100μl of 1:200 dilution of
PicoGreen® in Tris-EDTA buffer. Samples were measured in triplicate against
two  standards.  Flourescence  was  measured  on  a  Bio-Tek  Instruments, Inc.
(USA) FLX-800 Microplate Flourescence reader using 480nm excitation and
520nm emission. Results were expressed as ng DNA/hr.
2:4 Histological analysis
2:4:1 Fixation and embedding
All  samples  were  fixed  with  4%  paraformaldehyde, except  for  those
undergoing alkaline phosphatase staining which were fixed in 95% ethanol.
In order to allow accurate sectioning  all allograft samples were decalcified in
EDTA / Tris solution prior to embedding. Conformation of decalcification was
achieved by Imaging using a Faxitron® Specimen Radiography System MX-20
digital  with  Faxitron®  Specimen  DR  software  (Faxitron®  X-ray  Corporation,
USA). Samples were then suspended in PBS solution prior to embedding. For
paraffin embedding, samples were first dehydrated in graded ethanol solutions
then placed in 1:1 ethanol/chloroform solution, and finally in chloroform twice
for 1 hour before being soaked in paraffin wax at 60
oC twice. Samples were
embedded in hot wax and placed on a cooling surface to solidify.50
2:4:2 Slide preparation
A Microm 330 microtome (Microm International GmbH, Germany)  was used
for sectioning. The Paraffin wax embedded samples were removed from cold
room storage and trimmed of excess wax. 6μm sections were cut and placed
on a water bath at 37
oC and allowed to spread. Sections were captured onto
pre-heated glass slides and then transferred to a drying oven at 37
oC for 3
hours. Slides were stored at 4
oC and were warmed to room temperature prior
to staining.
2:4:3 Alcian Blue & Sirius Red staining
Histoclear was used to clear excess wax, the samples were then rehydrated by
passing through graded methanol solutions. Residual methanol was removed
in the water bath, and followed by nuclear staining with Weigert’s haemotoxylin
for 10minutes. Slides were rinsed in water and stained with Alcian blue for 10
minutes  to  demonstrate  proteoglycan  rich  cartilage  matrix. The  slides  were
then treated with molybdophosphoric acid for 20 minutes followed by staining
with 0.1% Sirius red F3B for 1 hour to demonstrate collagen. The sections
were then dehydrated through reverse graded methanol and histoclear steps.
2:4:4 Alkaline phosphatase staining
Alkaline  phosphatase  enzyme  activity  is  used  as  an  early  marker  for
osteogenic differentiation;  samples  were  incubated  with  a  colourimetric
solution  reactive  to  intrinsic  alkaline  phosphatase. Ethanol  fixation  of  the
samples  was  carried  out prior  to  histochemical  staining.  Naphthol  AS-MX
phosphate  and  Fast  Violet  B  salts  were  combined as  per  a  Sigma-Aldrich
protocol and applied to the culture samples. Following the development of a
red-purple stain the reaction was stopped with distilled  water. The samples
were placed in cold storage until imaged.51
Fig 2:3 Microscope image of a single CFU-F on tissue culture plastic following 14 Days
culture  in  basal  media.  Alkaline  phophatase  stain  performed  to  highlight  osteogenic
differentiation (pink) of the cells cultured from a single progenitor cell. Scale 100μm
2:4:5 Immunohistochemistry
Initially any endogenous peroxidase activity was arrested with 3% H2O2
for 5 minutes; sections were then rinsed with water and blocked with 1% BSA
in PBS for a further 5 minutes. Sections were incubated overnight at 4
oC with
the primary antibody. To remove any residual antibody, sections were rinsed
with water and passed through wash buffers of high salt, low salt  and tris for 5
minutes  each.  The  appropriate  biotin-conjugated  secondary  antibody  was
applied for 1 hour followed by further rinses in wash buffers. The secondary
antibody complex was linked with Streptavidin peroxidise and incubated for 30
minutes. Samples were developed using 3-amino-9-ethyl-carbazole (AEC) in
acetate  buffer  containing  H2O2,  to  yield  a  reddish-brown  reaction  product.
Nuclear staining with Weigert’s haemotoxylin, and an appropriate counterstain
was then applied followed by mounting in glycerol jelly. Negative control slides
were performed by omitting the appropriate primary antibody.52
2:5 Mechanical testing and IBG
2:5:1 Impactor design
Previous studies by Brewser et al, using force plate analysis have determined
the total force imparted during a standard femoral impaction bone grafting to
be equivalent to a 1.98kg mass falling 65mm onto a circular base plate 60mm
in diameter (Brewster, Gillespie et al. 1999). The bioengineering department at
Southampton  University  have  used  these  values  to  rescale  and produce
custom impactors for both  in  vitro  (large  impactor) and  in  vivo  experiments
(small  impactor).  Both  impactor  designs  were  based  on  a free  sliding  drop
weight  dropping  a  set  distance  onto  an  enclosed  chamber  which  could  be
sequentially filled with graft.
Fig 2:4 Photographs of Large  impactor used for in vitro studies. A: (i) Drop weight on
shaft. (ii) Impactor head engaged in base plate. (iii) Base plate with gap to accommodate
acrylic ring for graft containment.  B: (iv) Base plate with central opening through which
the  graft  is  introduced  into.    C:  Base  plate  and  Impactor  after  final  impaction  (v)
Impactor head. (vi) Base plate with central hole now filled with impacted allograft. The
acrylic ring containing the allograft is then carefully slid out of the base plate and an
acrylic base and lid added. Scale bars 20mm approx. The in vivo impactor was a similar
design but scaled down.
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2:5:2  Allograft Impaction
Using  the  modified  impactors described  in 2:5:1, Impaction  of allograft  was
carried out as described by Dunlop et al (Dunlop et al., 2003). The milled and
seeded allograft was introduced into the top of the impactor chamber in three
equal portions, to ensure even compaction. The weight was dropped 24 times
from the set height at a rate of approximately 1Hz for each portion of allograft
so that the finished pellet received a total of 72 impactions.
2:5:3 Shear testing
A custom made cam shear tester was used for all shear testing of the samples
as per Fig 2:5. The graft was carefully transferred into the chamber and an
axial load applied for 5 min before the shearing process began. Axial loads of
50N,  150N  or  250N  were  used  giving  compressive  stresses  of  102kPa,
306kPa and 509kPa respectively which are within the physiological stresses
encountered within the hip joint.
Fig 2:5 Schematic representation of the cam shear testing jig with photo of the set up
on the right.. The disc of allograft is the central yellow square. There is a fixed upper
ring  and  a  mobile base  plate  that  a  constant  shear  force  is  applied via  an  actuator
connected  to  the  lower  ring  in  the  direction  of  the  red  arrow.  Prior  to  shearing  the
sample an axial force is applied for 5 minutes at 3 different compressive loads (One per
sample) of 50N, 150N or 250N as represented by the blue arrow.
Axial Load
50, 150 & 250N
Fixed upper ring
Mobile lower ring
Graft Sample
Shear force54
Shear testing of the allograft under compressive loads gives rise to a family of
stress strain curves as shown in Fig 2:6 with each curve representing a single
sample. The  graphs  in  Fig  2:6,  2:7  and  2:8  show  the  data  from  the  cell
concentration study as detailed in Chapter 3, to demonstrate how the linear
regression plots are constructed from the base data.
Fig 2:6 Graph showing an example of a Family of Stress Strain Curves produced from
the mechanical shear testing. Each line representing a single samples behaviour. The
three distinct groupings of the lines are due to the three different axial compressive
loads 50, 150 and 250N
The shear strength value at 10% strain (an industry standard point) is then
determined and plotted against the value of the axial load (Normal Stress kPa).
See Figures  2:7 & 2:8.55
Fig 2:7 Graph showing 3 stress strain curves at increasing axial loads / normal stress.
The shear stress at 10% strain is calculated by extrapolating back to the y values as
demonstrated  by  the  arrows.  These  values  are  then  plotted  against  the  axial  load
expressed as normal stress in kPa
Linear regression analysis can then be performed on the values to find a best
fit line  (Fig 2:8)
Fig 2:8 Graph showing the 3 points plotted on the graph. Linear regression analysis is
then  used  to  find  a  best  fit  line  (blue  on  graph).  c  =  y  intersect  =  interparticulate
cohesion value. Φ = angle of slope = internal friction angle
If the samples obey the Mohr Coulumb law i.e there is a linear relationship
between the points (signified by a R
2 value close to 1) then the shear strength
(y intercept for a given Normal Stress level), Interparticulate cohesion (c = y
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intercept at 0kPa) and internal friction angle (angle of slope) can be calculated.
The Mohr Coulomb Law is expressed as follows:
Shear Strength τ = σtanΦ + c
c = particle cohesion
σ = axial stress
tanΦ = Internal friction angle
2:6 Statistical Analysis
Statistical analysis was performed using GraphPad Prism software (Ver 5). For
comparisons of the means, a two sample or ‘Student’s’ t-test was performed.
Linear  regression  analysis  was  performed  on  all  Shear  strength  data  with
correlation r
2 >0.98 for all. Comparison of multiple linear regression analysis
was performed using Analysis of Co-variance (ANCOVA). A p-value of < 0.05
was taken as significant and divided in this thesis as either <0.05, <0.01 or
<0.001. The number for all experimental runs is documented in the individual
experiments, but n > 3 for all. Error bars are equal to +/- 1 Standard deviation.57
SECTION I
The Biomechanical Effects of Skeletal Stem
Cell Concentration  in  Impaction  Bone
Grafting
Chapter 3:
The  Effect  of  Skeletal  Stem  Cell  Concentration  on  the
Biomechanical properties of Impacted Bone Graft
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Chapter 4:
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Chapter 3
The  Effect  of  Skeletal  Stem  Cell  Concentration  on  the
Biomechanical properties of Impacted Bone Graft
3.1 Introduction
Following increasing patient numbers undergoing primary hip arthroplasty, an
increase in patients requiring revision arthroplasty surgery has been seen. In
the  UK  between  2003  and  2008,  the  number  of  revision  hip  procedures
performed doubled to almost seven thousand per year (NJR 2008). Many of
these  patients  may  have  received  their  original  implants  when  joint
replacement surgery was in its infancy and the techniques, prostheses and
instruments  had  not  yet  been  refined.  Consequently,  these  patients  now
present in increasing numbers with extensive bone loss around loose implants
posing a significant orthopaedic challenge for revision surgery.
With almost a forty year history in revision hip surgery, impaction bone grafting
(IBG)  using fresh  frozen  morcellised  allograft remains  the  current  gold
standard for replacing lost bone stock (Schreurs et al. 1998). This technique
endeavours to recreate a solid, adaptive mantle into which the implant can sit
securely, immediately able to withstand forces associated with normal implant
use. The ability of the graft bed to resist shear and go on to form a new living
bony  construct  is  a  critical  factor  in  the  long-term  success  of  the  revision
implant. The results are encouraging, with up to 87% twenty year survivorship
for  acetabular  components  and  ten  year  femoral  component  survival  of
99%(Schreurs et al. 1998; Halliday et al. 2003) However, widespread adoption
of this demanding technique has not always led to a repeat of these results
outside of the major centres (Halliday et al. 2003), and thus laboratory based
research  endeavours  to  find  techniques  to  improve  the  desirable
characteristics of the allograft.60
Previous in vitro studies have identified both mechanical and biological factors
that  can  be  modulated  to  augment  the  structure  and  performance  of  IBG.
Factors,  such  as  preparation  of  graft,  constituent  particle  size,  chemical
additions  and  local  fluid  drainage  have  all  been  shown  to  affect  the
performance of IBG (Dunlop et al. 2003). The combination of skeletal stem
cells (SSC) with the allograft has become an area of particular interest for the
enhancement  of  impacted  allograft.  In  vitro  work  has  shown  that  SSC’s
combined  with  allograft  can  not  only  survive  the  impaction  process  and
continue to proliferate, but also improve the mechanical (shear) characteristics
(Bolland et al. 2006). In vivo (murine) studies have reinforced these findings,
but also show enhanced new vessel formation within the constructs and hence
raise the possibility of de-novo bone formation and survival  within the graft
tissue (Kanczler and Oreffo 2008).
The  accepted  method  for  replacement  of  allograft  in  IBG  is  via  creeping
substitution. The concept of a living graft which becomes incorporated into,
rather than replaced by the surrounding host tissue presents a paradigm shift
to the concept of allograft use.
The  beneficial  clinical  effect  of  autologous  bone  marrow  has  been  clearly
demonstrated by Hernigou et al in the treatment of fracture non-unions and
femoral head osteonecrosis (Hernigou, Poignard et al. 2005). For atrophic non
union cases it was established that the concentration of the aspirated marrow
was necessary to produce a therapeutic effect was above 1000 CFU-f/ml and
that  the  mean  concentration  in  bone  marrow  aspirate  is  approximately
600CFU-F/ml. Whilst the use of SSC in clinical practice has been established
for non unions, treatment of AVN and in the addition to IBG for acetabular
reconstruction (Deakin  and  Bannister  2007)  the  clinical  results  have  been
variable. This may be attributable to the variable concentration of SSC within
the bone marrow aspirate as noted by Hernigou. To my knowledge, no work
has  been  performed  to  establish  the  optimal SSC  concentration  for  use  in
impaction bone grafting.
.61
3:2 Null Hypothesis
The seeding density of SSC on to allograft has no effect on the biomechanical
properties of impacted bone graft
3:3 Aims
This aim  of  this  study  was  to  examine  both  the  biological  and  mechanical
characteristics  of  impacted  allograft  when  combined  with  increasing
concentrations of SSC’s and to analyse the effects of increasing SSC seeding
density on the IBG Shear strength
3:4 Study design
3:4:1 Cell Culture & Graft Preparation
As previously described in 2:1 and 2:2. P1 Culture expanded SSC were used
for all experimental runs harvested from the waste marrow of haematologically
normal patients undergoing elective THR. Cells were split off the culture flasks
as described and the concentration established via haemocytometer.
3:4:2 Graft Seeding
The allograft was seeded at 3 different SSC concentrations (5x10
3, 5x10
4 and
2x10
5 cells / cc allograft ) along with plain allograft as a negative control, and
the experiment was repeated for each cell concentration (and plain allograft
control),  giving  two  data  sets  for  each  cell  concentration.   These  seeding
densities  were  used  as  previous  experiments  by  Bolland  et  al  have
demonstrated  that  2  x  10
5  cells  per  cc  allograft  was  sufficient  to  cause  a
significant  increase  in  the  constructs  shear  strength.  This  has  therefore
established an upper limit, and this concentration was repeated in my study to
confirm reproducibility of the experimental set up. The lower concentrations of
5x10
3, 5x10
4 were used to refine the experiment further to try and establish the
lowest concentration required to cause a significant improvement in the shear
strength of the IBD  / SSC construct.62
Experimental Groups:
 Control - Plain Allograft
 5000 SSC / cc Allograft
 50000 SSC / cc Allograft
 200000 SSC / cc Allograft
Allograft  was  prepared  in  standard  fashion  as  previously  described  and
aliquoted into 10cc and placed in a falcon tube. The desired amount of SSC
were resuspended in α-MEM and then added to the allograft in a drip wise
fashion as described in section 2:2:3. The time was limited to 1 hour in order to
simulate  time  that  would  be  available  intra-operatively,  thereby  making  this
technique highly relevant for clinical translation.
3:4:3 Graft Impaction
Using the larger impactor as described in section 2:5:1, all samples underwent
3 stage impaction with a total of 72 blows at 1Hz. The compacted discs were
then contained in custom made acrylic discs to keep the allograft contained,
with multiple pores across the whole surface to allow free flow of culture media
in and out of the samples.
3:4:4 Tissue culture
The  contained  acrylic  discs  were  then  submerged  in  culture  media  within
sterile  pots  and  placed  in  an  incubator.  Regular  media  changes  were
performed  and  the  discs  cultured  for  a  total  of  2  weeks  as  this  had  been
previously  shown  to  be  an  adequate  culture  period  to    show  any  potential
differences (Bolland et al. 2006). A longer culture period significantly increased
the chance of infection with further cost and time implications and was not felt
to be required for this primary study. Once culture was complete, the samples
were sealed  within their containers, in culture media and transferred to the
mechanical testing jig within 3 hours.63
3:4:5 Mechanical shear testing
A custom made cam shear testing rig was set up as described by Bolland et al.
and fitted into an Instron testing machine (Instron, High Wickham, UK). This
composed of a chamber between two shear plates within which the graft was
placed (See section 2:5:3). Eighteen of the impacted discs were subjected to a
constant  shear  strain  of  1mm/min  whilst  under 3  different compressive
stresses of 50N, 150N and 250N (6 discs per stress), and from this data shear
strength, interparticulate cohesion and internal friction angle parameters were
calculated using the Mohr Coulomb failure equation:
Shear Strength τ = σtanΦ + c
3:4:6 Cell viability
Cell viability of the samples was assessed at day 0 to confirm attachment of
the cells and survival post IBG. Further analysis of cell viability was carried out
following 2 Weeks of incubation. This was achieved using Cell Tracker Green
probe and Ethidium Homodimer-1 as described in section 2:2:4.6465
3:5 Results
3:5:1 Mechanical shear testing
Linear regression analysis of the shear data gave an R
2 value >0.99 showing
that a close linear relationship existed and confirming that the samples were
suitable for further analysis. Using the Mohr Coulumb equation we can then
calculate the interparticulate cohesion of the samples.
Cellular concentration and Shear strength
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Fig 3:1. Linear regression analysis of the shear stresses at 10% Strain demonstrating
progressive  increase  in  shear  strength  and  interparticulate  cohesion  with  increasing
SSC concentration
2x10
5 HBMSC / cc
5x10
4HBMSC / cc
5x10
3 HBMSC / cc
Allograft66
As  shown  in  Table  (3:1)  and  Graph  (3:1)  (c  =  y  axis  intersection)  this
progressively  increases  with  increasing  cell  seeding  density.  The  shear
strength of the construct can also be calculated, in table (3:1) the values at
350kPA are shown with 350kPA being within the normal physiological load of a
hip  joint.  This  was  approaching  significance  at  5x10
4 cells/cc  (p=0.06),  and
highly significant at the 2x10
5level (p=0.001).
Cell
Concentration
(cells/cc
allograft)
R
2value for
linear
regression
Shear
Strength
At
350kPa
Interparticulate
Cohesion c
kPa
Significance
Grouped linear
regression
analysis
Plain Allograft >0.99 245.5 55.8 vs Plain
Allograft
5x10
3 >0.99 248.9 61.3 p=0.76
5x10
4 >0.99 272.2 75.6 p=0.06
2x10
5 >0.99 284.9 95.7 p=0.001
Table  3:1: The  effect  of  increasing  SSC  concentration  (cells/cc  allograft)  on  Shear
strength (τ) and Interparticulate cohesion(c)
3:5:2 Cell viability
Figure 3:2  shows  good  viability  of  cells  on  the  seeded  allograft  at  day  0
demonstrating  adherence  of  the  cells  to  the  scaffold,  and  survival  of  the
impaction process. It also confirms no contamination of any live cells in the
control  group. After  2  weeks  incubation  the  live  cell  density  (shown  by  the
bright green areas) clearly increases in keeping with ongoing cell division and
differentiation. In the two higher seeding densities new matrix formation can be
seen starting to bridge the gaps between the allograft chips.67
Fig 3:2 CTG live staining of samples at Day 0 post impaction and following 14 days of
culture. Scale bar 200μm
3.6 Discussion
This study shows that skeletal stem cell number has a measurable effect on
the impacted allografts’ mechanical properties at two weeks incubation. The
shear  strength  of  the  impacted  allograft  increases  in  combination  with
increasing  concentration  of  seeded  SSC.  At  5x  10
3  there  is  no  significant
difference, but this is approaching significance at a concentration of over 5x10
4
cells/cc of allograft. There is a 16% increase in strength of the disc as a whole
when seeded at 2x10
5cells/cc, and this turns out to be a 72% increase in the
interparticulate  cohesion. If  we  correlate  the  mechanical  results  to  the  Live
dead staining of the samples we can see that for the lowest seeding density
(5x10
3/cc)  at  2/52  the  cell  and matrix  coverage  of the allograft  is  still  fairly
sparse.  In  the  higher  concentration  groups  there  has  been  more  cell
proliferation  and  subsequent  matrix  formation  and  it  is  surmised  that  this
bridging  between  the  bone  graft  chips  of  the  cells  and  ECM  increase  the
cohesion between them, thus improving their shear strength.
Previous  work  performed  in  our  department  reinforces  the  mechanical
advantage of SSC seeded allograft compared to allograft alone, but there has
been no published research to date which investigates the effect of increasing
Day 0
Day 14
0 2x 10
5 5x10
4 5x10
368
cell seeding concentration in the IBG example. However, when investigating
the treatment of established tibial non-unions, Hernigou et al. injected the site
with concentrated aspirated bone marrow (Hernigou et al. 2005; Mont, Zywiel
et al. 2010). An increase in efficacy of the aspirate in promoting union was
found  when  the  SSC  concentration  was  increased  by  centrifugation  of  the
sample, demonstrated by parallel in vitro CFU-F counts. Of 60 patients treated
by this method, 53 progressed to union, and the seven persitent non-unions all
had lower CFU-F counts.
SSC’s are rare in bone marrow, representing less than 1 in 10,000 nucleated
cells. Given our finding that mechanical advantage in the IBG model is only
gained  at  concentrations  of  over 5x10
4 cells/cc  allograft,  this  also  has
important  implications  when  translating  this  work  to  theatre  as  it  is  clearly
important to know at which concentration the cells need to be seeded, in order
to confer the advantage to the patient as soon as possible. Clinically patients
can  be  weight  bearing  on  the affected  limb  from  very  early  in  the  post-
operative period, hence a clear increase in the construct strength from two
weeks will reduce the risk of stem subsidence as well as failure (in shear) from
an early stage. However, with this mechanical advantage requiring in the order
of 10
7 cells at operation (2 femoral heads = approximately 200mls allograft),
there are not enough SSC’s present in a pelvic aspirate to provide this number
of cells. Hence to translate this clinically there are three options:
i) In-vitro culture of autologous SSC’s, such that the numbers required
for  seeding  can  be  produced.  This  will  require  an  additional
procedure several weeks before the revision hip surgery.
ii) Intra-operative  concentration  (eg  by  centrifugation)  of  autologous
bone marrow aspirate.
iii) The use of donor SSC’s. This would allow the production of ‘off the
shelf’  seeded  allograft,  but  risks  infective  transmission  as  well  as
rejection.69
The  benefits  of SSC  seeded  allograft  are  however  not  only  mechanical.
Previous  work  by  our  group  with biochemical  and  histological  analysis  has
shown continued cell survival and proliferation after two weeks in culture. Col 1
staining  and  ALP  specific  activity  also  indicates  osteoblastic  differentiation.
Previous  studies  by  our  group  have also  shown  the  induction  of
neovascularistion by SSC seeded allograft in a murine model (Bolland et al.
2007). It is important that this occurs early during graft incorporation, to ensure
oxygen and nutrients can be provided to the proliferating cells hence when
translated to the clinical environment it can be hypothesised that the graft itself
will survive and replace the lost bone stock, rather than being replaced by the
surrounding bone, which can take in excess of 18 months. Furthermore, this
technology can be translated to other areas of orthopaedics, including fracture
non-unions, segmental bony defects and avascular necrosis.
3:7 Summary
The  combination  of  SSC’s  with  allograft  provides  interesting  and  clinically
translatable results. They appear to enhance the mechanical characteristics of
the  allograft,  as  well  as  providing  the  opportunity  for  graft  survival  and
incorporation. I have now shown that increasing cell seeding density further
enhances this activity and should be more than 5x10
4 cells/cc allograft.
3:8 Conclusion
The results in the context of the null hypothesis were examined:
Null Hypothesis
The seeding density of SSC on to allograft has no effect on the biomechanical
properties of impacted bone graft
This hypothesis is false7071
Chapter 4
Clinical  Translation  of  Enriched  Skeletal  Stem  Cell  cells
seeded onto allograft in the treatment of non union and AVN of
the hip.
4:1 Introduction
In chapter 3 I have demonstrated that SSC seeding density plays a critical role
in the in vitro biomechanical strength of the IBG construct, but that this only
occurs at a relatively high seeding density, and certainly significantly higher
than  that  found  in  bone marrow  aspirate  In  order  to  transfer  the  maximal
biomechanical  advantage  of  the  addition  of  SCC  to  the  IBG  construct  to
prevent  subsidence  or  failure  it  is  therefore  necessary  to  use  a highly
concentrated SSC sample. This chapter describes the translation of these in
vitro findings to the treatment of a number of orthopaedic conditions with the
use of a centrifuge based concentration system. Parallel in vitro analysis of the
samples is also undertaken.
Fracture non union can be caused by a number of conditions, both patient
factors  such  as  diabetes,  or  smoking  and  mechanical  factors  such  as
inadequate stability or bone loss / fracture gap. The non unions can be broadly
classified  as  hypertrophic  or  atrophic.  Atrophic  non  union  occurs  when  the
fracture ends loose any potential for callus formation / osteogenesis usually
due to a loss of local blood supply in the early phase of fracture healing (Reed
A et al 2003). It has been demonstrated that Skeletal stem cells can induce
angiogenesis (Kanczler and Oreffo 2008) and if used in combination with a
scaffold may be able to induce union of the fracture. The SSC concentration
has also been shown by Hernigou to be a critical factor (Hernigou et al. 2005).
Avascular Necrosis (AVN) of the femoral head is a disease that usually affects
young patients with the average age in the USA requiring THR for complete
collapse being 38 (Solacoff D et al 1993). Causes of AVN can be either post73
There  are  a  number  of  other  scoring  systems  but  the  main  crux  of  the
diagnosis and staging are whether the femoral head sphericity is maintained
(Stage 1 and 2) or if there has been collapse and loss of the bony architecture
(Stage  3  &  4).  Once  there  has  been  collapse  of  the  head,  the  treatment
options  become fairly  limited  with  rapid  progression  to  OA  and  subsequent
THR as appropriate. For the earlier stages of the disease, prior to collapse of
the femoral head, there are a wide number of treatment modalities that have
been  used  in  an attempt  to  arrest  the  seemingly  inevitable  disease
progression.   These  range  from  simple  protected  weight bearing  for  small
areas of AVN with Cheng et al 2004 showing spontaneous resolution of some
lesions. More prolonged follow up by Henigou et al 2004 and metaanalysis of
819 non operatively treated hips by Mont MA however have shown  that 73 -75
%  will  eventually  progress  and  require  operative  intervention,  so  protected
weight bearing is no longer recommended. Phamacological treatment has also
been  studied,  with  the  bisphosphonate:  Alendronate  used  to  treat  100 hips
(Agarwala  et  al  2005)  by  preventing  osteoclastic  bone  resorption.  They
demonstrated clinical improvement in outcome disability scores at 1 year mean
follow up with only 10% requiring surgical intervention. It should be noted that
the follow up length was a mean of 1year and 5 years maximum, so again as
per Hernigou’s study a significant proportion of these may go on to collapse.
Core  decompression  of  the  femoral  head  has  been  used  as  a  surgical
treatment for AVN for a number of years. The principle behind the technique is
that it decompresses the head, reducing intramedullary pressure and removes
the necrotic area of bone.  A metaanalysis of 1206 hips that underwent core
decompression showed an overall clinical success rate of 63.5% (Mont MA et
al 1996) with less than 33% requiring replacement or salvage procedure at last
follow up. Core decompression doesn’t provide any initial mechanical support
however, and  relies  on  angiogenesis  and  new  bone  formation  from  the
surrounding  tissues,  and  it  has  been  well  documented  that  in  AVN  the
osteoprogenitor  numbers  are  reduced (Hernigou  et  al.  1999; Calder  et  al.
2001).74
Porous Tantalum implants used in combination with core decompression has
also been used with the Tantalum strut providing the mechanical support and
allowing  bony  in  growth  into  the  implant.  Prospective  analysis  of  60  hips
treated  with  this  method  by  Veillette  et  al  (2006)  showed  a  survival  of  the
femoral head in 68% of cases at 4 years follow up. A smaller study of 22 hips
by Shuler et al (2007) showed 86% survival at a minimum 2 year follow up of
grade  1  and  2  disease.  These  results  are  encouraging,  but  have  the
disadvantage of using a metal implant rather than replacing the native bone
stock which may lead to more demanding surgery should the need for revision
to THR be required.
Vascularised  free  fibula  grafting  for  hip  AVN  could  be  considered  the  gold
standard  treatment,  as  it  is  replacing  the  necrotic  area  of  bone  with  native
living bone and providing immediate structural support and an established new
blood supply. The results of this technique from a number of studies involving
over 300 hips in total (Zhang 2000; Marciniak 2005; and Yoo et al 2008) all
show significant improvements in Harris hip scores at last follow up with only
10% requiring conversion to THR at 10 years follow up in Yoo et als study.
Although the results from Marciniac et al are less favourable with 61% and
42% survival of the femoral head at 5 and 8 years respectively.  It should also
be  noted  that  the  surgical  technique  for  this  method  is  both  technically
demanding and time consuming and in the UK would be likely to require the
input of a reconstructive / plastic surgeon as well.
More recent work by Hernigou (Hernigou et al 2009) and others have used
SSC  and  or  Allograft  IBG,  but to  our  knowledge no  study  has  been  done
looking at the combination of concentrated SSC and IBG for the treatment of
AVN.75
4:2 Aims
The purpose of this study was to see if the findings from the previous chapter
of increased biomechanical strength with increasing SSC concentration can be
clinically translated to improve patient outcome for a number of conditions.
4:3 Null Hypothesis
(i) The use of a centrifuge concentrated bone marrow aspirate in combination
with impacted allograft does not improve the treatment of fracture non union or
AVN of the hip
(ii) Parallel in vitro culture of the samples does not demonstrate any biological
advantage compared to the unconcentrated sample.
4:4 Clinical Methods
4:4:1 Patient Cohort
Fracture non-union:
one case was identified as a suitable candidate for the procedure. The patient
was a 72 yr old female who had originally undergone a Right THR complicated
by  a  sciatic  nerve  injury.  She  had  significant  co  morbidities  of  diabetes,
hypertension, hypercholesterolemia and had a high Body Mass Index.  As a
result  of  her  sciatic  nerve  palsy  she  fell  and  sustained  an  intraarticular
bicondylar distal femoral fracture. (Fig 4:1)76
Fig (4:1) Plain radiographs demonstrating  A (AP) and B (LAT) of Distal bicondylar T
shaped fracture.  C: Second plating with contoured locking plate after initial metalwork
failure. Note fracture line still clearly visible
This was initially treated with a DCS plate which subsequently failed and was
revised to a locking distal femoral plate (locked proximaly and distally). Despite
adequate reduction and good fixation of the fracture, it failed to unite with no
change  in  the  xray  apearence  over  4  months  and  a  CT  scan  Fig (4:2)
confirmed  non  union.  There  was  no  clinical  or  haematological  signs  of
infection.
Fig(4:2) Coronal CT scan of distal femur showing established atrophic non union.
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4:4:2 Avascular Necrosis:
A total of four cases of femoral head AVN were treated as part of this study.
The basic patient parameters were as follows
Patient Age Attributed
Cause
Right
hip
stage*
Right  hip
treatment
Left hip
stage*
Left  hip
treatment
1 42 Systemic steroids
for  sub-arachnoid
haemorrhage
IV THR II SSC/IBG
2 40 Alcohol III THR II SSC/IBG
3 31 Idiopathic III THR II SSC/IBG
4 32 Systemic  steroids
for  testicular
carcinoma
II SSC/IBG II SSC/IBG
Table of patient parameters, aetiology and treatment
*Ficat & Arlet Stage (Ficat 1985)78
4:4:3 Bone Marrow Harvest and Concentration
After informed consent under asceptic conditions in theatre a standard bone
marrow aspiration was performed from the iliac crest. Due to the volume of
bone  marrow  aspirate  required  (120ml),  care  was  taken  to  try  and  gain
maximum  yield  with  minimal  contamination  from  systemic  blood.  This  was
achieved by multiple passes of the Jamshee needle with only small volumes
aspirated before twisting to 90Deg and withdrawing. In 3 of the 4 cases both
iliac crests were utilised.
Fig 4:3 A: Aspirating the Rt iliac crest for bone marrow harvest. HARVEST syringes,
filters and centrifuge pots can be seen in the foreground. B: Close up of the marrow
aspiration via a jamshee needle cored into the iliac wing
Once  120ml  of  sample  had  been  collected  the  bone  marrow  was
anticoagulated with 8ml Anticoagulant Citrate Dextrose Solution A (ACD-A) as
per the manufacturers guidelines. The sample was placed in a blood giving set
and passed across a filter. The filtered sample was then carefully decanted
into  the  centrifuge  pots.  This  particular  device  worked  on  a  floating  shelf
principle  to  separate  the  buffy  coat  from  the  red  blood  cell  fraction.  Other
centrifuge systems were available and all worked on broadly similar principles.
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Fig 4:4 A: HARVEST centrifuge with patented bone marrow pots filled with the bone
marrow  aspirate.  B:  Post  centrifuge  the  concentrated  fraction  containing  the SSC  is
segregated within a separate compartment. 1 = Plasma, 2 = Concentrated mononuclear
cell layer. 3 = floating plastic shelf designed to separate off cell fraction. 4 = waste red
blood cells.
Once  the SSC  containing  fraction  of  the  bone  marrow  aspirate  had  been
separated  out  by  the  centrifuge,  the  excess  plasma was  then  aspirated  off
leaving a few ml. this was then used to re-suspend the buffy coat layer which
was then drawn off and transferred back to the operative field. At this stage the
milled allograft can be seeded with the concentrated sample and was allowed
to stand with frequent agitation whilst the surgery was performed.
4:4:4 Surgical technique
 Under image control a guide wire was passed into the affected area, for the
cases  of  AVN  prior  MRI  scans  of  the  hip  had  localised  the  necrotic  area
involved.  Once  the  surgeon was  satisfied  the  guide  wire was  appropriately
placed, a 12mm cannulated drill was passed up the guide wire under Image
control. The drill was advanced until it rested just under the subchondral bone
thus achieving initial core decompression. Any further necrotic bone proximally
could then be curetted out.
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The  seeded  allograft was  then  compacted  using  a  12mm  Xchange  core
impactor (Stryker,  Newbury  UK).  The  impactor  containing  the  allograft was
then  advanced  up  the  canal  under  the  subchondral  bone  and  impacted  in
place with great care taken not to ‘blow out’ the thin overlying  cortex. This
process was then repeated until the drilled out channel was filled with a solid
core of impacted allograft and concentrated SSC.
A similar technique was used for the fracture non union with the guide wire
passed across the fracture line and the sclerotic bone ends over drilled and
packed with IBG as above.
Fig4:6 A: core  decompression  being progressively filled  up  with  the  sample  of
concentrated marrow and allograft. B: final result with arrows highlighting new dense
core of impacted allograft and concentrated BMA.
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4:5 Parallel In Vitro Methods
Any  waste  allograft  and  bone  marrow  aspirate  was  collected  with  the
appropriate  consent  and  local  ethics  committee  approval.  Unfortunately  no
waste  concentrated  sample  was  available  for  one  of  the  AVN  cases  so
comparative analysis was not available.
4:5:1 CFU-F Count
A CFU-F is defined as a colony of cells derived from a single progenitor cell
and  can  be  used  to  determine  the  concentration  of SSC  within  the  bone
marrow aspirate.
Equal  volumes  (0.5ml)  of  concentrated  (BMAC)  and  unconcentrated  (BM)
bone marrow were plated straight into culture flasks to allow comparative CFU-
F counts to be made.
At 2 weeks the culture plates were fixed with 95% Ethanol and an Alkaline
Phosphatase  stain  with Napthos  AX-MX  and  Fast  violet  B  Salts was
performed.
4:5:2 qPCR analysis
Further Tissue culture flasks were cultured to near confluence and then fixed
and processed for quantative PCR analysis for Type 1 Collagen, Osteocalcin
and  Alkaline  Phosphatase  gene  expression.  This  analysis  was  kindly
performed by Miss S Inglis.
4:5:3 Cell Viability
Spare Allograft  was  seeded  with  both  the  BMAC  and  BM  samples  and
impacted and contained within capsules and cultured in basal media ( α-MEM
+ 10% FCS). The samples were cultured for up to 6 weeks dependant on the
quantity of the waste allograft and BM / BMAC available.
Samples were analysed for cell viability at 0, 2, 4 and six weeks using a live /
dead stain of Cell tracker green and Ethidium Homodimer (Sigma Aldrich Ltd,
Gillingham) as previously described.82
4:5:5 Histology
Samples from each group was analysed histologically. The allogaft underwent
decalcification in 0.1% TRIS / 5% EDTA solution and complete decalcification
was confirmed by faxitron xray imaging. Samples were sectioned and mounted
in standard fashion. Slides were stained for collagen and extracellular matrix
production  using  Alcian  Blue  and  Sirius  Red  (A+S),  and  to  establish
osteogenic  differentiation  of  the  cells  they  also  underwent
immunohistochemical staining for collagen 1 and bone sialoprotein (BSP).
4:5:6 Biochemistry
Four capsules were retained for biochemical analysis of DNA content (as a
measure  of  cell  number),  and  specific  alkaline  phosphatase activity  (as  a
measure of osteogenic differentiation).  Cells were removed from the allograft
using trypsin, collagenase and multiple vortexing. Allograft was discarded, cells
were fixed in ethanol and cell lysates were obtained via x3 freeze thaw cycles
in Triton X. ALP and DNA assays were then performed in a standard manner
with 10µl of lysate run in triplicate for each disc on a plate against x2 standards
and read on a Bio-Tek KC4 and FLX-800 microplate fluorescent reader (Bio-
Tek, USA).83
4:6 Clinical Results
4:6:1 Fracture Non-union
The one case of fracture non union has now clinicaly and radiologicaly united
and has been discharged from further follow up after over 2 years with an un
united fracture prior to biological intervention with concentrated SSC grafting.
Her pain control and mobility have improved as a result. There has been no
signs of failure of the metalwork.
Fig (4:6) Plain Radiographs showing A: Before and B: after BMAC seeded IBG showing
on the left the initial fracture line clearly visible , and on the right good callus formation
with bridging bone.
4:6:2 AVN Cases
To date 3 of the cases have remained asymptomatic with no radiological signs
of femoral head collapse at 25 – 47 month follow up. Patient 4 progressed on
to  collapse  both  femoral  heads  and has subsequently undergone  bilateral
THRs. Histological and mechanical testing carried out by Mr A Aarvold on the
retrieved  femoral  heads  has  shown  a  dense  central  channel  of  bone  with
trabeculae crossing into the sample consistent with bone remodelling. Micro
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CT analysis of the bone has shown a density profile between that of trabecular
and cortical bone.
Fig 4:7 AP and Lateral Radiographs showing  Rt THR performed for advanced collapse.
Left hip asymptomatic, grade II AVN treated with Concentrated SSC and allograft with
dense channel of IBG just visible in the superior head and neck.
Fig 4:8 Plain radiograph showing  AP view of Bilateral core decompression and SSC
seeded IBG85
4:7 Results of Parallel In Vitro Analysis
4:7:1 CFU-F
Fig 4:9 Alk Phos staining of CFU-F on T25 tissue culture flasks following 2/52 culture.
Control BM samples on the left of each photo with concentrated / BMAC on the right.. A;
Patient 1. B: Patient 2. C: Patient 3. Scale bars 20mm
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There  was  significant  variability  in  the SSC  yield  from  the  bone  marrow
aspirate  between  each  patient  as  can  be  seen  in  figure  4:9.  There  are  a
number  of  factors  that  affect  the  SSC  yield  including  patient  age  and  co
morbidities, and also the technique of obtaining the aspirate. The best yield
from this small study occurred in patient 3 who was the youngest of the cases
with no underlying conditions or obvious cause for his AVN. All samples did
however  undergo  significant  concentration  of  the SSC  fraction  using  the
centrifuge  device. The  CFU-F  in  the  unconcentrated  group  are sparse,
particularly in patients 1 and 2 (A&B Fig 4:9) and considering the large surface
area of tissue culture plastic (TCP) compared to the individual allograft chips,
minimal  seeding would  have  occurred   on  the  allograft.  The  concentrated
fractions show marked increase in coverage of the TCP, particularly in patient
3:
Fig 4:10 Photomicrograph of T25 Flask following Alk Phos staining of CFU-Fs with un
concentrated sample BM on the left and Concentrated BMAC on the right. Scale bar
20mm
The CFU-F counts were as follows:
Patient
BM
Sample
(Number +/- SD)
BMAC
Sample
(Number +/- SD)
p value
1 4.66 +/- 1.2 61 +/-12.1 0.01
2 21.3 +/- 3.5 143 +/- 18.5 <0.01
3 87.3 +/- 16.5 412 +/- 40.1 <0.01
Table  4:1  CFU-F  counts  for  BM  and  BMAC  samples  in  all  3  patients  showing
significantly increased counts
BM BMAC87
Physical counting of the individual number of CFU-Fs was performed using a
grid background. Table 4:1 shows that all three patient samples which were
taken straight from the theatre setting and plated up in the labs without further
manipulation show a highly significant increase in CFU-F following centrifuge
separation with p = / <0.01.
4:7:2 Biochemistry
Four  seeded  allograft  samples  from  each  group  were  analysed  for  DNA
content  and  Alk  Phos  Specific  activity.  Plain  allograft  samples  were  also
analysed and the values obtained for the allograft subtracted from the BM /
BMAC totals as this was considered the ‘background noise’ from retained cells
within the allograft and not subjected to the experimental variables. Of note
these background values (not included in the graph below, but subtracted from
the total values for BM and BMAC) declined over the 4 week culture period
presumably due to the repeated washing during media changes.
The graph below (Fig 4:11) demonstrates that there was an increase in DNA
content over the 4 week culture period confirming on going cell division with
increase in both concentrated and in control samples.88
Fig 4:11 DNA content as measured by Pico Green assay. Control BM and Concentrated
BMAC samples at 2 and 4 week culture. Error bars denote 1SD. P values as shown.
The mean amount of DNA at both 2 weeks and 4 weeks was significantly
greater in the concentrated BMAc group compared to standard bone marrow
aspirate as the control with p<0.01 and p<0.05 at 2 and 4 weeks respectively.
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Fig 4:12: Alkaline Phosphatase Specific Activity for control and concentrated samples
cultured on Allograft for 2 and 4 weeks. Error bars denote SD. P values as documented.
Figure  4:12 demonstrates an  increase  in  the  levels  of Alkaline phosphatise
activity  over  the  4  week  culture  period  indicative  of  ongoing  osteogenic
differentiation  of  the  samples.  Comparing  the  unconcentrated  control  and
concentrated group shows a highly significant difference between the 2 with
p<0.01 and p<0.001 at 2 and 4 weeks respectively.
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4:7:3 Quantative PCR
Below are graphical representations of the qPCR results for Patients 1 and 3.
Unfortunately the sample for Patient 2 was contaminated during processing
and no spare samples due to the limited supply of BMAC / BM was available.
The DNA sample for Patient 1 unconcentrated was also very small with only
sufficient amount for Col 1 and Osteocalcin analysis, but as Alk Phos activity
had been measured via quantitive biochemical assays it was felt the other two
markers for osteogenic differentiation were more important.
Fig 4:13 Quantative PCR Graph showing the relative expression of the Osteocalcin gene
as a marker for osteogenic differentiation of the SSC all normalised to  βActin. P1 –
Patient 1, P3 = Patient 3, BMAC = Concentrated group, BM = unconcentrated
Mean values n=3 with duplicate runs for each. SD for error bars
Osteocalcin is  a  bone-specific  protein  synthesized  by  osteoblasts  that
represents a good marker for osteogenic maturation. The graph in Fig 4:13
shows  that  the  relative  expression  of  Osteocalcin  was  significantly  higher
(p<0.01) in the concentrated group for patient 1 compared to the control and
approaching significance for patient 3.
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Fig 4:14 Quantative PCR Graph showing the relative expression of Type I Collagen gene
as a marker for osteogenic differentiation of the SSC all normalised to  βActin. P1 –
Patient 1, P3 = Patient 3, BMAC = Concentrated group, BM = unconcentrated
Mean values n=3 with duplicate runs for each. SD for error bars
Relative expression of Type 1 Collagen was also significantly increased by the
concentration process, this time for both Patient 1 and 3 with p<0.001 and
p<0.05 respectivly.
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Fig  4:15  Quantative  PCR Graph  showing  the  relative  expression  of  the  Alkaline
Phosphatase gene as a marker for osteogenic differentiation of the SSC all normalised
to  βActin.  P1 –  Patient  1,  P3  =  Patient  3,  BMAC  =  Concentrated  group,  BM  =
unconcentrated. Mean values n=3 with duplicate runs for each. SD for error bars
As discussed earlier, sadly there was insufficient quantity of sample for the
control  group for  patient  1  but,  given  the observed  differences  in  the other
biochemical assays this may have shown a difference, and when compared to
the relative values of patient 3 as shown in Fig 4:15 there was a comparatively
high relative expression rate. The sample from Patient 3 showed higher levels
that were approaching significance, but due to the large error bars this was not
statistically significant.
4:7:4 Live / Dead Staining
At set intervals during parallel in vitro culture of the samples (5, 14, 28 and 42
Days) the samples were stained with fluorescent markers to demonstrate cell
viability  and  necrosis.  Fig  4:16  Shows examples  of the  control  and
concentrated samples showing fairly sparse seeding initially, particularly in the
control  group.  However  by  day  28  there was  significant  coverage  of  the
allograft surface with a layer of viable SSC
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Fig 4:16 Flourescent microscopy images of Live / Dead fluorescent staining of seeded
allograft at 5, 14, 28 and 42 days (Due to a finite quantity of the waste allograft available
following  the  clinical  case, no  further  BM  samples  were available for  analysis  at
42days). Viable / live cells green, dead cells red. Scale bar 200μm
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At Day 28 in the concentrated group the cells and matrix are demonstrated
bridge the gap between the allograft particles which was less evident in the
unconcentrated samples at this stage. By Day 42 the spiculated form of the
allograft chip has been almost completely covered and smoothed off by the
abundant cellular and matrix proliferation. Fig 4:17 Shows this in more detail
with the Allograft now artificially highlighted by blue we can see the initial bare
allograft chip in figure A, which by week 6 in figure B has now become covered
in  viable SSC  with  bridging  cells  and  matrix  now  bonding  the  separate
fragments together.
Fig 4:17 Further Live dead fluorescent microscopy images at 6 weeks culture (BMAC
Group  only)  with  the  cellular  layer  (green  arrow) now  enveloping  the  allograft  (blue
arrow) and bridging the gaps. A: Representation of the bare allograft B: Allograft and
SSC. Scale bar 100μm
On a number of BM samples, particularly the early ones, large collections of
aggregated dead red blood cells are noted. These had a tendency to prevent
SSC proliferation in that area, although as the culture progressed with multiple
media changes these clumps of dead cells were washed off.96
From the microscopy images we can see the initial SSC becoming adherent to
the allograft, and then progressively covering the surface and finally bridging
the gaps between trabeculae and other allograft particles.
4:7:5 Histology
Representative histological samples of the allograft seeded with the
concentrated BMAC and un concentrated bone marrow are shown in Fig 4:18
at 2 weeks and Fig 4:19 at 4 weeks. Comparing to the plain allograft (which is
the current gold standard in IBG) there is significantly more matrix formation
and Type 1 collagen differentiation. Comparing the BM and BMAC samples
the differences are less clear cut, but there does appear to be increased matrix
(signified by the blue staining on the A&S run). On the immunohistochemical
slides  again  the  differences  are  not  marked,  but  there  does  appear  to  be
greater  area of Type 1 collagen signified by the brown staining. The Goldners
Trichrome slides, looking for new osteoid formation may demonstrate a little
increase  in  new  bone  at  2weeks  although  there  do  not  appear  to  be  any
significant differences at the 4 week stage.97
Fig  4:18 Microscopy  images  of  Histological  slides  at  2 weeks  culture  with allograft
marked by: *. Scale bars 200μm
A-Aii A&S Staining of plain allograft, BM and BMAC samples showing no cell or matrix
for  the  control  plain  allograft  but  widespread  matrix  production  (Blue)  in  both SSC
seeded groups, but more pronounced in the BMAC sample.
B-Bii Type 1 Collagen staining of plain allograft, BM and BMAC samples. Brown colour
denotes Type 1 Collagen with slightly more staining in the BMAC compared to BM
C-Cii Goldners Trichorome stained samples of allograft, BM and BMAC. No significant
new mineralised bone was observed.
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Fig  4:19 Microscopy  images  of  Histological  slides  at  4 weeks  culture  with  allograft
marked by: *. Scale bars 200μm
A-Aii  A&S  Staining  of  plain  allograft,    unconcentrated  BM  and    concentrated  BMAC
samples showing no cell or matrix for the control plain allograft but widespread matrix
production (Blue arrow) in both SSC seeded groups, at 4 weeks the increased matrix in
the BMAc group is more evident.
B-Bii Type 1 Collagen staining of plain allograft, BM and BMAC samples.. In the BM
group some of the matrix has stained for type 1 Collagen, compared to the concentrated
group where thick densly stained areas for type 1 Collagen are seen (Brown Arrows)
C-Cii Goldners Trichorome stained samples of allograft, BM and BMAC. Small areas of
mineralised bone are starting to form in both samples (Green Arrows).
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4:8 Discussion
Although only one case of fracture non union was treated during this study
period, we have demonstrated that the bone marrow sample has undergone
significant concentration of the SSC fraction, and when used in combination
with IBG has gone on to unite finally.  Although no control / unconcentrated
sample  was  used  clinically,  parallel  in  vitro  analysis  has  shown  improved
osteogenic differentiation. This supports the findings of Hernigou (Hernigou,
Poignard et al. 2005).
The treatment of AVN remains a challenging clinical problem and despite a
number of surgical treatment options any failure can quickly progress to loss of
head sphericity and subsequent degenerative changes. Whilst conversion to a
Total  hip  replacement  remains  the  ultimate  option  should  this  occur,  these
patients are often young and preservation of the native hip should be the long
term goal of future therapies. Core decompression +/- impaction grafting has
been the treatment of choice for AVN for some years; however both methods
require new bone formation and ultimately replacement of the IBG by creeping
substitution.  It  has  been  shown  however  that  in  cases  of  AVN  there  is  a
significant  reduction  in  number  of  osteoprogenitor  cells,  and  the  disease
process on a cellular level can extend below the lesser trochanter (Hernigou et
al. 1999; Calder et al. 2001). Histological retrieval analysis of IBG without the
addition  of SSC  has  shown that  whilst  revascularisation  does  occur  and
subsequent  remodelling,  there  remains  areas  of  fibrous  tissue (Ling et  al.
1993; van der Donk et al. 2002) which as the graft bed thickens may be more
of a problem due to the distance from any new vessel formation. To address
this problem, Tilley et all have described the addition of bone marrow aspirate
to IBG in the treatment of AVN and femoral bone cysts (Tilley et al. 2006) with
encouraging signs of bone integration and remodelling.
Whilst the numbers included in this study are clearly small, the principle of
replacing  a  dead  necrotic  area  of  bone  with  a mechanically supportive
construct  that  has  the  potential  for  angiogenesis  and  new  bone  formation
appears sound.  On review of the case that progressed on to femoral head
collapse post bilateral IBG the extent of the disease on pre op MRI may not102
have been fully appreciated. Retrieval analysis of the femoral head specimens
carried  out by  our  research  group  have  shown  the  IBG  and SSC had
incorporated and remodelled well, but further areas of the femoral head more
lateral to the treated area subsequently collapsed.
The parallel in vitro culture of the samples has allowed a detailed assessment
of  the  potential  benefits  of  the  concentrated SSC  fraction  which  we  have
demonstrated  as  giving  significantly  higher SSC  yield  and  subsequent
proliferation.  The  BMAC  samples  also  showed  improved  osteogenic
differentiation  crucial  for  new  bone  formation  to  give  a  new  solid  bony
construct that will hopefully continue to maintain the femoral head architecture
for years to come.
Obtaining highly concentrated SSC within the theatre setting can be difficult to
achieve. The centrifuge system used for this experiment has the advantage of
being able to deliver that concentrated sample within the theatre and without
the need for staged bone marrow harvest as is the case for culture expansion.
The sample does however need to be passed out of the sterile field to undergo
centrifugation and although the fluid remains sealed there are a number of
steps where contamination could potentially occur.  Although concentration of
the SSC fraction has been achieved by up to 13x, it should be noted that the
total number of SSC per ml was still low ranging from just below 8 to 165 CFU-
F per ml pre concentration, well below the values obtained by Hernigou et al.
Part of this may be attributed to the underlying disease process with lower
numbers known to be a factor in AVN. Another issue is the harvesting of the
bone marrow itself, because large volumes of aspirate are required (120ml) in
order to get sufficient concentration and coverage of the IBG there is a risk of
reducing the yield with venous blood pooling around the marrow. Blood also
poses a problem during tissue culture as the high number of red blood cells
tends to form a carpet on the graft or tissue culture plastic, potentially blocking
adhesion  of  the SSC  and  this  was  noted  for  a  number  of  the  early  CTG
analysis. Strategies to reduce the rbc ‘contaminate’ and further enhance the
SSC concentration and harvest ideally all within the sterile field of the theatre103
setting  are  therefore  likely  to  improve  this  technique  further  and  ultimately
improve the clinical outcome for a potentially debilitating condition.
4:9 Summary
Parallel  in  vitro  assessment  of  the  tissue  engineering construct  and
subsequent  retrieval  analysis  has  given  a  unique  insight  into  the  bone
regeneration in these clinical cases. The results from this study of significant
SSC  concentration,  ongoing  proliferation  and  osteogenic  differentiation  are
encouraging  for  the  treatment  of  AVN  of  the  femoral  head. It  remains  an
ongoing study with further cases occurring recently.
4:10 Conclusion
Null Hypothesis
(i) The use of a centrifuge concentrated bone marrow aspirate in combination
with impacted allograft does not improve the treatment of fracture non union or
AVN of the hip
Due  to  the  small  number  of  cases  in  this  study  I  cannot  refute  the  null
hypothesis,  but  the  study  is  on  going  and  further  cases  will  allow  a  more
definitive  assessment  of  the  outcomes  compared  to  the  current  surgical
practice.
(ii) Parallel in vitro culture of the samples does not demonstrate any biological
advantage compared to the unconcentrated sample.
This has been shown to be false.104105
SECTION II
Enhancing the Osteogenic Differentiation of
Skeletal Stem Cells
Chapter 5
The Effect of Type 1 Collagen on the Biomechanical properties
of SSC Seeded Impacted Bone Graft
The initial part of this study was performed in conjunction with Miss Tsin Foong
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Mechanical testing was done in collaboration with Dr Andrew New
Chapter 6
The  use  of  Hydroxyapatite  nanoparticles  to  enhance  the
biomechanical properties of Impaction bone graft
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Chapter 7
In Vivo Study on the biological effects of Type 1 Collagen and
Hydroxyapatite on SSC IBG construct
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Chapter 5
The Effect of Type 1 Collagen on the Biomechanical properties
of SSC Seeded Impacted Bone Graft
5:1 Introduction
Type  I  collagen  is  a  key  extra-cellular  matrix  (ECM)  protein  and  the  major
collagen of tendon and bone. It is important for both structural support within
the ECM, but also provides key control of cell proliferation and differentiation
(Dawson, Wahl et al. 2008).
Type 1 collagen is made up of a triple helical structure of alpha chains (2 alpha
1  and  1  alpha  2).  It has  been  shown  to  improve  SSC  adherence  to
extracellular  matrix  proteins  with  a  strong and  rapid  bond formed  within  30
minutes (Salasznyk,  Williams  et  al.  2004). Proliferation  and  osteogenic
differentiation  are  also enhanced  by  contact  with  type  I  collagen,  causing
SSCs to express osteogenic genes (Mizuno and Kuboki 2001; Datta, Holtorf et
al.  2005; Tsai,  Kao  et  al.  2010) with  the  collagen  integrin  interaction  an
important signal for triggering osteoblastic differentiation.
Fresh frozen allograft contains a substantial proportion of type I collagen, but I
postulate that the number of binding sites may be reduced or inactivated by
the processing  and/or  preservation  of  the  allograft.  Here I hypothesise  that
coating  the  entire  surface  of  milled  allograft  with  a  purified  layer  of  type  I
collagen increases the number of active binding sites and enhance adherence
and osteogenic differentiation. Whilst a number of the studies referenced have
shown  that  collagen  coated  scaffold  or  tissue  culture  plastic  can  induce
enhanced osteogenic differentiation, to my knowledge no work has been done
on allograft. Morcellised allograft remains the gold standard for replacing lost
bone stock in IBG and the use of collagen has FDA approval and is used in
other medical fields. I propose that the combination of the two in the presence
of SSC  has  the  potential  to  form  a  new  bony  construct  with  enhanced
biomechanical factors compared to plain allograft alone.108
5:2 Null Hypothesis
1. Coating of milled allograft with Type 1 Collagen prior to seeding
with SSCs will not improve cell adhesion to the construct.
2. Coating of milled allograft with Type 1 Collagen prior to seeding
with SSCs will not improve the osteogenic differentiation of the
cells on the construct
3. Coating of milled allograft with Type 1 Collagen prior to seeding
with  SSCs  will  not  enhance  the  mechanical  properties  of  the
construct
5:3 Aims
The aim of this study is to analyse the potential benefits of coating of allograft
with type 1 Collagen in an attempt to improve osteogenic differentiation and
the constructs biomechanical properties.
5:4 Materials & Methods
5:4:1 Type 1 Collagen
A sterile solution of Rat tail type 1 collagen (Sigma Aldrich) was used in this
study. The Type I collagen was diluted with PBS to 0.25 mg/ ml. Aliquots of 6
ml  were  applied  to  10  cm
3  portions  of  milled  allograft,  which  ensured  graft
coverage and produced a final type I collagen load of 1.5 mg on 10 cm
3 of
milled  allograft.  These  were  left  for 2  hours  to  allow  adsorption  onto  the
allograft surface, according to manufacturer’s instructions. The allograft was
then  left  to dry under  UV  light  and  washed  with  PBS prior  to  seeding  with
SSCs.109
Fig 5:1 Coated allograft contained in sterile pots and allowed to air dry under uv light
5:4:2 Allograft
Prepared as previously described in section 2:1. Briefly, fresh frozen femoral
heads were thawed, then milled into variable sized bone chips. The chips were
then washed and de fatted with hydrogen peroxide. Half the sample was then
coated with Type 1 Collagen as described overleaf, with the remainder used
as the plain control.
5:4:3 Cell Culture
HBMSC  were  harvested  from  consenting  patients  undergoing  THR,  and
culture expanded in basal media as described in section 2:2. P1 basal culture
expanded SSC were used throughout this experiment.
5:4:4 Histology
One  disc  from  each  group underwent histological analysis. The  discs
underwent decalcification in EDTA until completion, as measured by faxitron
imaging. Slides were stained for collagen and extracellular matrix production
using Alcian Blue and Sirius Red (A+S).
5:5 Study Design
The allograft was split into 2 groups with plain allograft as control and Collagen
Coated as the experimental arm. In each group  15 samples were used for
biomechanical analysis, 4 samples for biochemical assays and 1 sample for
histological slides.110
The allograft was divided into aliquots of 10cc and the graft seeded with basal
cultured cells at a concentration of 5x10
4 cells / cc . The graft was placed on
an agitator within the incubator for 1 hour and then impacted with the large
drop weight into the containing acrylic discs. These were then cultured in basal
media for 2 weeks before undergoing mechanical testing with the custom cam
shear jig, and analysis for DNA content and Alk Phos activity.
Fig 5:2 Experimental sequence. A: allograft contained within sterile pot being seeded
with SSC  in  drip  wise  fashion  via  pipette.  B:  Following  1Hr  of  Culture  in  incubator
samples  then  impacted  with  drop  weight  impactor  into  contained  acrylic  discs. C:
Samples  then  cultured  in  incubator  for  2  weeks  covered  in  basal  media,  contained
within the acrylic discs in sterile containers as shown.
A B C111
5:6 Results
5:6:1 Mechanical enhancement:
Shear  testing  of  the  constructs  and  subsequent  linear  regression  analysis
using the Mohr Coulumb equation revealed a significant improvement in the
grafts  ability  to  resist  shear  and  the  interparticulate  cohesion  between  the
allograft chips
Fig  5:3 Linear  regression  graph  demonstrating  increased  shear  strength  of  collagen
coated  allograft  over  plain  allograft  in  the  presence  of SSC.  Lower  blue  line
representing  plain  allograft  and  cells.  Higher  Red  line  representing  Collagen  coated
allograft and cells. p=0.04
The linear regression analysis shown in figure 5:3 demonstrates that firstly the
samples have a good correlation with linear increase and an r
2 value of >0.98.
Both slopes are of a statistically similar angle which in this aggregate example
signifies  a  similar  grading  to  the  two  experimental  groups  of  allograft.
Extrapolation of the shear strength from the graph at 350kPa normal stress is
shown in table 5:1 along with the interparticulate cohesion from the value at
the y axis intersection.
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4 Cells/cc
Allograft
Shear Strength
kPa
Cohesion c
kPa
Basal Control 272.2 75.6
Collagen 302.3 113.3
Table  5:1  Absolute  values  of  shear  strength  calculated  from  the  linear  regression
analysis at a 350kPa Normal stress. Interparticulate cohesion calculated from the y axis
intercept.Shear Strength and interparticulate cohesion are significantly enhanced by the
addition of collagen coating. N=5
The above results show a significant increase in both the shear strength and
interparticulate cohesion (p<0.05) following coating of the allograft with Type 1
Collagen.
5:6:2 Biochemical Analyses of IBG samples
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Fig  5:4  Alkaline  Phosphatase  specific  activity  for  the  plain  allograft  + SSC  controls
(Green)  vs Collagen Coated Allograft and SSC (Blue). Mean +/- SD n=4113
Fig 5:4 Shows that by the simple addition of a fresh type 1 collagen coating on
the allograft bone chips, there is a significant enhancement in the osteogenic
differentiation of the SSC seeded onto the scaffold 0.026+/- 0.04 vs 0.01+/-
0.02 mmolpNPP/hr/ng DNA (p<0.05).
DNA Assay of in vitro capsules
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Fig  5:5 Pico  green  DNA assay  of  Plain  allograft + SSC  (Green)   vs  Collagen  coated
Allograft + SSC (Blue). Mean +/- SD n=4
There  was  however  no  significant  difference  in  the  DNA  content  of  the
samples.  As  both  samples  were  seeded  with  the  same  number  and
concentration of SSC, DNA content was used as a marker for cell adherence,
as although these results are following 2/52 culture, if more cells had adhered
at the start of the culture process, then by the time of analysis the difference
should have been even more marked with exponential expansion. Although
there are other cofounding variables that may have influenced this result and
analysis  immediately  following  seeding  may  have  been  a  more  precise
measure,  the  net  aim  was  to  see  if  there  was  sustained  increased SSC
proliferation to enhance the biomechanical properties of the graft.114
In  order  to demonstrate  a  visual  difference  in  the  degree  of  osteogenic
differentiation between the two groups to go along with the quantitive assays,
half of a 6 well culture plate was coated with type 1 Collagen prior to seeding
and basal culture.  Alkaline Phosphatase staining was then performed , the
results of which are shown below:
Fig  5:6  Photomicrograph  showing  six  well plate  14  Days  after  seeding  with  equal
concentrations  of SSC  into  each  well.  Alkaline  Phospatase  staining  performed  to
demonstrate marked increase in ALP activity in the Collagen coated group.
The marked difference in staining again strengthens the argument that type I
Collagen coating can improve osteogenic differentiation.
Collagen Coated
Wells
Plain
Wells115
5.7 Discussion
Type  1  Collagen  is  abundant  within  the  allograft,  but  this  study  has
demonstrated that by coating the allograft with a fresh layer of Collagen the
biomechanical  properties  can be  enhanced.  As  the  cavitatory  defects
encountered in clinical practice increase, so the need for improved biological
and mechanical function of that graft bed needs to be enhanced. Its role is  to
provide a solid resistance to shear in the post operative period to allow early
return to weight bearing and function, and also enhance new bone formation to
form a living construct that can support and remodel around the new implant. I
have demonstrated that Type 1 collagen coating can significantly enhance the
shear  strength  after  2  weeks  of  culture. I have  also  shown  that  Type  1
Collagen  can  improve  the  osteogenic  (as  depicted  by  the  raised  Alk  Phos
assays) differentiation  of  the SSC  confirming  similar  results  to  previous
studies(Mizuno and Kuboki 2001).
In Mizunos study they used a type 1 collagen matrix and analysed both the
ALP  specific  activity  and  also  the  expression  of  gene  expression  of  the
osteogenic markers ALP , Osteocalcin, Osteopontin and Bone Sialoprotein at
1,2 and 3 weeks. They showed that at week 1 the differences between the two
groups  was  minimal,  but  by  2  weeks  there  was  significantly  increased
expression of ALP. Mineralisation of the samples only started to occur around
the  three  week  stage.  Although  no  qPCR  analysis  was  performed  in  this
experiment, the early signs of mineralisation of the Type 1 Collagen coated
samples were observed on the 6 well plates (Fig 5:7) and similar ALP results
were observed in our study.
Fig  5:7    CFU-F  on  Collagen  coated  TCP  at  2  weeks  culture  showing  early  central
mineralisation (arrow). Scale bar 200μm116
It has been shown that Type 1 collagen can form a rapid bond with SSC within
30min (Salasznyk et al. 2004) however the results from my study did not show
any significant increase in DNA activity between the two groups. Measurement
of DNA quantity is not a direct measurement of the SSC’s rate of adhesion and
there are many factors that may have affected the result. The samples were
seeded and incubated for 1 hour prior to IBG as this protocol had worked for
previous experiments, but it may be that this time was too long and the plain
control group was able to bind with the majority of the SSC in that time. Further
work should therefore be directed at analysing how short a time is required for
the  collagen  coated  allograft  to  bind  sufficient SSC  as  the  shortest  time
possible is advantageous within the theatre setting.
This study has confirmed the finding of others namely that Type 1 Collagen
does  appear  to  trigger  osteogenic  differentiation  within  the  stromal  cell
population (Mizuno et al 2001; Salasznyk et al 2004). The exact mechanism
for  this  is  not  fully  understood,  but Mizuno was  able  to demonstration  that
collagen a2-β1 integrin interaction was an important signal for the osteoblastic
differentiation of bone marrow cells. This study has taken these results further
by showing that not only does enhanced osteogenic differentiation occur, but
that there is also a significant enhancement in the mechanical properties when
used in the IBG setting. I postulate that whilst the quantity of cells present was
not significantly different to the control, greater amounts of mineralised matrix
are being produced by the enhanced osteogenic cell differentiation leading to a
stronger bridging between allograft chips thus increasing the shear strength.
Direct measurement of the strength of osteoblast like cell adhesion at a cellular
level has been studied by Takai et al. They observed that the strength of bond
as  measured  by  the  elastic  modulus  of  the  cells  to  various  ECM  proteins
including Type 1 collagen was significantly greater when compared to cells
cultured on glass (Takai et al 2005).
So from the evidence from this study and the literature I conclude that Type 1
Collagen  promotes  rapid  and  strong  stromal  cell  adherence,  enhanced
osteogenic  differentiation  and  subsequent  increased  mineralised  matrix118119
Chapter 6
The  use  of  Hydroxyapatite  nanoparticles  to  enhance  the
biomechanical properties of Impaction bone graft
6:1 Introduction
(HA)  is  a  naturally-occurring  mineral  that  comprises  the  major  inorganic
constituent  of  bone  which  was first  confirmed  by  Dejong  in  1926 (Dejong
1926). Its probable first use in Orthopaedics was in crystalline powder form for
the treatment of fractures by Albee, F. H., and Morrison in 1920 and shown to
improve callus formation (Albee 1920). Due to its non-toxic, non-inflammatory,
osteoconductive  properties  and  its  structural  characteristics,  it  has  enjoyed
widespread  application  as  a  surface-coating  for  orthopaedic  implants  to
promote osseous integration (Trikha et al. 2005)
Its use in modern Orthopaedics came to prominence with the coating of the
Furlong  hip  stem  which  commenced  in  1985 (Furlong  and  Osborn  1991;
Furlong 1993) which continues to show exceptional clinical results to date with
99% survival at 13 years (Shetty et al. 2005).
The functionality of HA has recently been further exploited by biotechnological
innovation, which has allowed the synthesis of HA nanoparticles (HAp) within a
colloidal  suspension (Zhou et  al.  2008).  This  technique  provides  a  useful
method of delivery at the cellular level, putatively allowing integration between
the  beneficial  properties  of  cells  within  impacted  graft  with  the  mechanical
advantages of HA. It is thought that the concerted action of the cell and HA
within bone graft will act synergistically to improve the graft’s characteristics.
The enhancement of osteogenic differentiation has been shown in 3D pellet
culture (Babister et al. 2009), but no study to my knowledge has analysed the
biological and mechanical effects when used in combination with allograft and
SSC.120
6:2 Aims
This  study  was  designed  to  assess  the biological  and  mechanical
enhancement of IBG allograft when seeded with SSC that have been cultured
with HA nanoparticles. And to assess the practicalities of transferring these
techniques into the operating theatre
6:3 Null Hypothesis
1. Coating  of  milled  allograft  with SSC  cultured  with  HAp
nanoparticles will not improve the osteogenic differentiation of the
cells on the construct
2. Coating  of  milled  allograft  with SSC  cultured  with  Hap
nanoparticles will not enhance the mechanical properties of the
construct
6:4 Materials and Methods
6:4:1 HA nanoparticles
Aqueous  colloidal  suspensions  of  arginine-functionalised  HA  nanoparticles
were prepared as previously described (Gonzalez-McQuire R 2004; Babister,
Hails et al. 2009). Briefly, an aqueous solution of 1M CaCl2 and 2M arginine
was prepared (50 ml, pH 9). This was cooled to 9C and an aqueous solution
of 0.33M Na2HPO4 (50 ml, pH 9) was added dropwise at a rate of 13 ml h
-1,
with  vigorous  stirring.  The  reaction  temperature  and  pH  were  maintained
during the addition. After completion of the addition of the phosphate solution,
the  temperature  was  increased  to  50C.  The  pH  was  monitored  and
maintained at 9 for a further 1 hour. The reaction solution was then aged at
50C,  with  continued  vigorous  stirring  for  a  further  15 hours,  resulting  in  a
stable colloidal solution. The HA/amino acid nanoparticles were sterilised by γ–
radiation at 2500 rads for 5 hours prior to formation of the cell/HA conjugates.
To prepare the cells treated with HAp, P1 culture expanded human SSCs were
trypsinised and suspended in basal media The HAp colloid was then added to
the cell suspension in universal tubes (20 ml per million cells, 7 x 10
8 particles121
per cell) and incubated for 1 hour before the sample was re-spun, washed to
remove any excess HAp and resuspended in media prior to seeding on the
scaffold.
Fig 6:1 Electron microscopy image of Hydroxyapatite nanoparticles in solution. Scale
Bar = 200nm
6:4:2 Allograft Seeding
SSCs  were  seeded  onto  each  sample  of  allograft  at  the  specific  seeding
density of 5x10
4 cells per cm
3 of allograft. Following trypsinisation from tissue
culture flasks, cell number was determined using a haemocytometer and cells
were suspended in equal aliquots of 5x10
5 cells in 6 ml basal media, this being
the volume necessary to cover 10 cm
3 of milled allograft. Cell suspensions
were added to sterile pots containing milled allograft and placed on an agitator
within the incubator for 1 hour to optimise cell adherence prior to impaction.
This  period  was  limited  to  1  hour  in  order  to  simulate  time  that  would  be
available intra-operatively, thereby ensuring relevance for clinical translation.
6:4:3 Graft impaction and culture
As described in the cell concentration and Collagen studies and section 2:5:2.
The larger impactor was used and a total of 15 HAp SSC + Allograft discs and
16 Controls of plain allograft and SSC were impacted and then cultured for 2
weeks in basal conditions.122
6:4:4 Mechanical testing
Using the custom cam shear tester 12 control and 12 HAp IBG discs were put
under  3  compressive  loads  and  sheared  at  a  constant  rate  until  failure  as
previously described in section 2:5.
6:4:5 Biochemistry
4 Control and 4 HAp discs were retained for DNA and Alkaline phosphatise
assays and processed as before as described in section 2:3.
6:4:6 Electron Microscopy
A further experimental run was performed to enable more detailed examination
of the samples in collaboration with Miss L Hails. Cell harvest, expansion, Graft
preparation, HAp seeding and impaction of the graft along with the 2 week
culture was performed by myself, the final sample preparation and scanning
was performed by Miss Hails.
Identical  steps  as  above  were  taken  for  the  preparation  and  culture  of  the
samples, the only difference being the smaller impactor was used to impact
into customized perforated electron microscopy pots see Fig 6:2. These were
cultured in tandem with the larger samples in basal media for 2 weeks and
then processed as detailed below.123
Fig 6:2 A: Allograft having been removed from the capsule, fixed and freeze dried ready
for  processing  as  below.  B: Small  perforated modified electron  microscopy  capsule
used for containment during culture of the sample.  Scale bar 5mm
For  SEM,  TEM,  EDXA  and  ultramicrotomy,  samples  were  fixed  using  4%
paraformaldehyde  in  PBS  (pH  7.2).  IBG  samples  for  chemical  and  SEM
analysis  were  fixed  and  freeze  dried.  For  ultramicrotomy,  samples  were
stained with osmium tetraoxide and subsequently embedded in low viscosity
resin (Agar Scientific Ltd, Stansted, UK). 50-75 nm thin sections were prepared
and observed by TEM after post-staining with lead citrate and uranyl acetate
stains.  For  TEM  imaging,  a  JEOL  JEM  1200  EX  Transmission  Electron
Microscope (JEOL UK Ltd, Welwyn Garden city, UK) was used. SEM analysis
was performed using a JEOL JSM 6330F Scanning Electron Microscope and
an Oxford Instruments ISIS 300 system (Oxford Instruments, Abingdon, UK)
was  used  to  obtain  Energy  Dispersive  X  Ray  Analysis  (EDXA)  data  of  the
samples.
6:4:7 Analysis by Fourier Transform Infrared (FTIR) Spectroscopy
IBG samples were fixed in 4% paraformaldehyde in PBS, washed 3 times with
deionised water and freeze-dried before processing into potassium bromide
(KBr)  disks  for  analysis  using  a  Perkin  Elmer  Spectrum  One  FTIR
spectrometer (Perkin Elmer, Cambridge, UK).
A B124
6:8 Results
6:8:1 Mechanical Shear Testing
HAp seeding of the SSC prior to IBG caused a significant improvement in the
grafts  ability  to  resist  shear  under  physiological  loads.  There  was  also  a
significant rise in interparticulate cohesion from 75.6 to 89.4kPa (p<0.05)
Fig 6:3 Graph demonstrating linear regression analysis of the stress strain results at
10% Strain. Allograft and SSC in blue and HAp and SSC in Red. After 2/52 culture in
basal media
Linear  regression  analysis  showed  good  correlation  with  r
2>0.98  confirming  the
aggregate obeyed the Mohr Coulumb failure law. Although the slopes of the two lines
observed in Fig 6:3 look different, on further statistical analysis (ANCOVA test) there
was  no  significant  difference  (p>0.05)  implying  that  the  composition  of  the  graft
aggregate was similar for experimental and control groups. Extrapolation of the shear
strength at a physiological load of 350kPa along with the interparticulate cohesion are
shown  in  table  6:1.  Demonstrating  a  significant  (p<0.05)  increase  in  the  shear
strength.
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Basal Control 272.2 75.6
HAp 309.0 89.4
Table  6:1 1  Absolute  values  of  shear  strength  calculated  from  the  linear  regression
analysis at a 350kPa Normal stress. Interparticulate cohesion calculated from the y axis
intercept. Shear Strength and interparticulate cohesion are significantly enhanced by
the addition of HAp seeded SSC (p<0.05) n=5
6:8:2 Biochemical analysis of cultured capsules
Biochemical analysis of the samples with Pico Green assay for DNA content
revealed no significant difference between the two groups.
DNA Assay of in vitro capsules
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Fig 6:4 Pico green assay for DNA content in control and HAp samples. N= 4 p>0.05126
Alkaline phosphatise specific activity was used as a marker for the amount of
osteogenic differentiation between the two groups. Fig 6:5 shows a graphical
representation of the difference with the basal control at 0.10 +/- 0.02 vs HAp
sample 0.18 +/- 0.03 mmol pNPP/Hr/ngDNA which was significantly different
(p<0.05).
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Fig 6:5 Alkaline Phosphatase specific activity for the control and HAp  samples. N=4
p<0.05
6:8:3 Alkaline Phosphatase staining of monolayer culture
The  biochemical  assays  have  demonstrated  a  quantative  difference  in  the
osteogenic differentiation of the HAp cultured cells. In order to demonstrate a
more visual representation of the difference, the two groups were also cultured
in monolayer on 6 well plates, the only difference being half of the sample
undergoing  prior  addition  of  the  HAp  as  described  above.  After  14  Days
culture, an Alkaline Phosphatase stain was then performed. A photograph of
the result is shown in Fig 6:6 and 6:7 demonstrating a marked increase in ALP
activity for the HAp group.127
Fig 6:6 Alkaline Phosphatase  stain on 6 well culture plate with half seeded with normal
SSC and half with SSC cultured with HAp. Both then cultured in basal media for 2/52
Basal Control
Fig 6:7 Photomicrograph of the six well plate in Fig 6:3. A: Basal control on left, B: HAp
on Right showing marked increase in Alkaline Phosphatase staining. Scale Bar = 500ɥm
Increased early signs of matrix mineralisation were also observed in the HAp
sample.
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6:8:4 Electron Microscopy
TEM imaging  as  seen  below  has demonstrated  stromal  cells,  which  have
incorporated HA into vesicles within the cytoplasm (Figure 6:8).  Although the
mechanism is not fully understood large amounts are seen within the cells with
little remaining in the extracellular space.
Fig  6:8  TEM  image  of  Skeletal  Stem  Cell  in  section.  Blue  arrows  highlight  Cell
membrane.  Grey  arrows  highlight  vesicle  within  cell  containing  multiple  HAp
nanoparticles, the small dark rods highlighted by the yellow arrows. Scale bar 1000nm
Microtomy of IBG samples after 21 days clearly identified extracellular matrix
production  in  basal  and  HAp/R-treated  samples  (Figure  6:10  a  and  c
respectively) and HBMSCs at the allograft chip surface (Figure 6:10 b).  Areas
of mineralisation, distinct from the allograft can be seen along with new matrix
produced by HBMSCs in regions between adjacent allograft chips in HAp/R-
treated samples (Figure 6:10 e, shown without post-stains for clarity and at
higher magnification). In addition, possible mineralisation of the collagen fibres
may be seen in sections of the nanoparticle treated sample (Figure 6:10 c and
d, indicated by arrows).129
Figure 6:10 TEM images of IBG samples in cross-section stained with uranyl acetate
and lead citrate:
a: Basal control, scale bar = 1 µm
b - d: HA-treated, Scale bars = 2 µm, 500 nm, 1 µm
e: HA-treated, unstained, scale bar = 1 µm.
A = allograft, C = collagen, HAp = hydroxyapatite particles, arrows demonstrate areas of
mineralised collagen.
SEM  analysis  of  the  IBG  samples  showed  a  significant  amount  of  new
extracellular  matrix  production  for  samples  cultured  with  and without  HA130
(Figure 6:9 ai,  bi)  compared  with  the  untreated  morselised  allograft  (Figure
6:6c).
We can see in Fig 6:9c that the surface of the plain allograft remains bare
compared to the cell cultured samples where cells and matrix can be observed
deposited  across  the  surface  of  the  bone  chips  and  providing  cohesion
between the individual pieces of allograft (Figure 6:9 ai, bi and d).
Fig  6:9  SEM  micrographs  of  IBG  samples  (a)  Basal  control SSC  showing  cells  and
matrix covering allograft. (b) HA nanoparticle group with cells and matrix coating the
allograft (c) plain allograft showing no covering to bare trabeculae.. Scale bar 100 μm
(aii) and (bii Higher magnification of Basal SSC control and HAp samples respectively
showing  matrix  forming  spherulite  like  particles  thought  to  be  an    early  marker  for
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mineralisation. Scale bar 4 μm, (d) Further SEM image of HAp-SSC sample showing
adherent cells and matrix bridging across to separate allograft fragments. Scale 10 μm.
The  newly  formed  matrix  on the  allograft  surface  showed  signs  of
mineralisation including the formation of spherulite-like particles, thought to be
associated  with  the  initial  stages  of mineralisation (Poulsson,  Mitchell  et al.
2009).  Although  these  were  observed  in  both  HA  and  basal  samples,  the
apparent mineralisation is more extensive in the former (Figure 6:9 aii, bii).
6:8:5  FTIR spectroscopy
Comparison  of  HA-SSCs  with  the  basal  SSC  control,  suggests  a  higher
mineral  content  in  the  nanoparticle-treated samples.   The mineral  to  matrix
ratio for HA-treated samples was found to be comparable with that obtained
from the original allograft (Figure 14).  This difference in composition may be
significant  in  influencing  the  mechanical properties  of  the  impacted  sample.
Carbonates to mineral ratios were also found to be the same for the allograft
and HA-treated IBG samples.
Matrix Mineral
Basal 1 2.40
HAp 1 5.25
Allograft 1 5.25
Mineral Carbonate
Basal 1 0.022
HAp 1 0.023
Allograft 1 0.023
Table 6:2 Relative composition of cultured IBG samples from FTIR analysis.132
6:9 Discussion
The results from this array of investigations are encouraging for the use of HA
nanoparticles  to  enhance SSC  differentiation  down  an  osteogenic  lineage.
Alkaline phosphatise stain and assays have both shown significant increase in
activity  levels.  Electron  microscopy  images  have  shown  signs  of  increased
mineralisation within the HAp group compared to the control and this would
support  the results  of  mechanical  testing  in  which  the  HAp  group  had  a
significantly higher shear strength and interparticulate cohesion. As the SSC
divide and cover the surface of the allograft chips, and the extracellular matrix
deposited starts to mineralise, so the bond between the particles increases
resisting the shear forces applied.
FITR  Spectroscopy  has  also  shown  increased  mineralisation  with  a  higher
mineral to matrix ratio compared to the basal controls. DNA concentration was
not  significantly  different from  the  controls  suggesting  there  was  no
enhancement  in SSC  attachement  or  rate  of  proliferation,  which  was  as
expected.
Previous work (Babister et al 2009; Gonzalez-McQuire et al 2007) has focused
on the 2D and  3D culture of SSC and HAp with significant improvement in the
osteogenic differentiation. To my knowledge this is the first study to show that
these observed effects can be extrapolated to use with allograft in IBG and
have a pronounced effect on the invivo mechanical strength.
Although the HA  nanoparticles  used  in  this  study  are  not  yet approved  for
clinical use, the transfer of these techniques into theatre should be feasible
although  access  to  a  centrifuge  and  a  tissue  culture  incubator  would  be
required in the vicinity.
One concern that had been raised during presentation of these results was the
safety of having IGB containing the HAp cultured nanoparticles in the vicinity of
a  highly  polished new  hip  replacement as a  potential  source for  third  body
wear and or immune response.  Although there is likely to be some excess
particles during the initial mixing phase and culture, the samples then undergo
centrifuge and repeated washing which is likely to reduce the ‘free floating’
debris significantly. It is also worth noting that the nanoparticles do not appear
to stay on the surface of the cells, but rather are taken up and incorporated by
the SSC (see figure 6:5).133
For transfer to clinical use, further work would also be required on analysing
any distant effect of the nanoparticles as the effects on other cell types and
transfer to distant organs is not fully understood. Due to the ability to attach
various agents to the HAp, their use as vectors for delivering therapies has
also been studied and one study looking at the effect of HAp on pulmonary
surfactant showed significant changes to the lining of the respiratory tract after
exposure  to  HAp (Qihui  Fan  et  al  2011).  Whilst  the  HAp  used  for  this
experiment is in solution and not necessarily of similar form, it does highlight
the need for further studies before clinical application is considered.
The mechanism by which the HAp particles act to induce osteogenesis is still
not  fully  understood.  Various  techniques  using  florescent  labelled  probes
attached to the HAp particles to try and demonstrate the reaction pathway in
living  cells  have  been  tried  but  as  yet,  unsuccessful  (Tanaka  et  al  2001;
Zumbuehl et al 2004; Tatton et al 1997).
There  is  considerable  development  of  a  huge  variety  of  Hydroxyapatite
structures and HAp nanoparticle compounds at present with a large number of
patents being filed for the differing structures (Yurong c et al 2008). Ostim is a
commercially available compound made up of crystalline HAp that comes in
paste  form  and  has  been  used  to  good  effect  in  bone  regeneration  for
periodontal defects (Heinz B et al 2009).134
6:10 Summary
HA nanoparticles pose an exciting potential for regenerative treatment for bony
defects.  Hydroxyapatite  already  has  a  good  reputation  for  the  coating  of
implants so transferring it’s potential osteogenic benefits in to clinical practice
should not be too much of a psychological step change for the orthopaedic
surgeon. The main disadvantage with the current technique is the requirement
for  tissue  culture  and incubation  which  could  all  be  potential  sources  of
contamination along with the logistical issues.
6:11 Conclusion
Null Hypothesis
 Coating  of  milled  allograft  with SSC  cultured  with  HAp
nanoparticles will not improve the osteogenic differentiation of the
cells on the construct
This hypothesis has been shown to be false
 Coating  of  milled  allograft  with SSC  cultured  with  Hap
nanoparticles will not enhance the mechanical properties of the
construct
a. This hypothesis has also been shown to be false135
Chapter 7
In  Vivo  Study  on  the  biological  effects  of  Type  1
Collagen and Hydroxyapatite on SSC IBG construct
7:1 Introduction
The in vitro studies have demonstrated the potential for both Type 1 Collagen
and  HA  nanoparticles  to  enhance  the  osteogenic  differentiation  of SSC
progenitors. In the setting of Impaction bone grafting this is highly desirable. To
assess  the  potential  for  these  techniques  to  be  transferred  into  the  clinical
setting it was deemed appropriate to assess the in vivo response using an
established  mouse  model (Bolland  et  al.  2008).  The  control  of  osteogenic
differentiation and new bone formation is a complex process involving many
synergistic  processes  under  the  control  of  various  growth  factors  and
hormones as described earlier. It is impossible to replicate these effects fully in
the in vitro setting thus the need to transfer to a live animal. For the purpose of
this  experiment  a  mouse  model  was  used.  There  are many  advantages  to
using the mouse model initially, including cost and time issues, but the model
is not without its disadvantages. The samples were contained within modified
electron microscopy pots to maintain containment of the IBG construct, and
whilst  they  will  be  subjected  to  the  various  hormonal  stimuli  from  the  host
animal, there is no mechanical strain or stimulation of the tissue. Ultimately to
replicate the clinical setting for IBG, the samples need to be under cyclical
loading  in  a  contained  bony  cavity  with  bone  to  IBG  and  IBG  to  cement
interface. This is not feasible for a mouse model and is best reproduced using
a  sheep  hemiarthroplasy  model,  but  due  to  various  factors  this  was  not
possible  during  my  period  of  study,  but  large  animal  studies  are  now
underway.136
7:2 Aim
To analyse whether the observed in vitro benefits of Collagen coated allograft
and HAp cultured SSC have the same effect on the osteogenic differentiation
under physiological conditions in an in vivo mouse model.
7:3  Null Hypothesis
HAp  cultured SSC  and  Collagen  coated  allograft  has  no  effect  on  the
osteogenic differentiation of SSC when cultured in an in vivo subcutaneous
mouse model
7:4 Materials and Methods
Separate allograft samples were prepared, seeded and impacted as previously
described, but using scaled down chambers appropriately sized for the mouse
dorsum.  Electron microscopy pots were modified to form perforated capsules
containing 1cm
3 of graft using a scaled-down impactor to replicate the femoral
IBG  process. Allograft  samples  were  seeded  with  SSCs,  impacted  and
cultured in vitro overnight before implantation.
Male  MF-1  nu/nu  immunodeficient  mice  were  purchased  from  Harlan,
Loughborough,  UK  and  acclimatized  for  a  minimum  of  1  week  prior  to
experimentation. All procedures were performed after prior ethical approval in
accordance with regulations specified by the Animals (Scientific Procedures)
Act 1986.
A total of 16 mice were used for this experiment with 4 groups:
(i) Plain Allograft
(ii) Plain Allograft and Basal SSC
(iii) Collagen Coated Allograft and Basal SSC
(iv) Plain Allograft and HAp cultured SSC
8 capsules were used for each group in total, with 5 for biochemical analysis,
and 3 for histological analysis.
The  animals  were  anaesthetised  with  fentanyl-fluanisone  (Hypnorm)
(Janssen-Cilag Ltd, High Wycombe, UK) and midazolam (Hypnovel) (Roche
Ltd, Welwyn Garden City, UK) in sterile water at a ratio of 1:1 and a dose of137
10ml kg
-1 intraperitoneally. The capsules were implanted subcutaneously on
the rear flank of the animal.
Fig 7:1 A: Mouse with 2 Capsules implanted subcutaneously in both flanks. B: After 28
Days the animals were euthanized and a midline sternotomy and laparotomy performed.
Scale bar 10mm
After 28 days the animals were anaesthetised and a midline sternotomy was
performed.  The left ventricle was cannulated and perfused with heparinised
normal saline until clear blanching of the liver occurred (Figure 7:2B). A pre-
prepared solution of Microfil (consisting of a lead chromate-containing radio-
opaque  polymer,  Microfil  MV-120  blue  and  MV-diluent  solutions  (1:1),  MV-
curing  agent  (10%  of  total  volume))  was  infused  at  a  constant  rate  and
pressure until the dye was visible in the ear, tail and mesenteric veins (figure
7:3A&B),  indicating  complete  perfusion  of  the  peripheral  circulation.  The
samples  were  then  harvested  (figure 7:4),  fixed  in  paraformaldehyde  4%,
scanned in using an Xtek Benchtop 160Xi scanner (Xtek Systems Ltd, Tring,
UK) equipped with a Hamamatsu C7943 x-ray flat panel sensor (Hamamatsu
Photonics, Welwyn Garden City, UK) followed by decalcification for histological
analysis as described .
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Fig: 7:2
A: Mouse post laparotomy and midline sternotomy (i) showing heart and (iii) liver. (ii)
Injection  of  heparinised  saline  with  22  Gauge  needle  into  left  ventricle.  (iv)
Subcutaneous capsule containing IBG and SSC.
B: Close up of Heart and Liver following initial flushing of vascular bed with heparinised
saline  showing  blanching  of  liver  from  the  blood  filled  state  seen  in  (iii).  Scale  Bar
10mm.
Fig 7:3
A: Mouse  intestine  post  infusion  of  microfil  demonstrating  complete  filling  of
mesenteric vessels
B: Mouse tail showing vessel filling with microfilm. Scale 10mm
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7:5 Results
7:5:1 New Blood Vessel Formation
Surgical dissection of the plastic capsules revealed a tissue capsule containing
multiple fine vessels surrounding the sample and penetrating through into the
graft bed. Although this was the case for the majority of the capsules, some
where observed to be relatively avascular with little or no signs of new vessel
formation or tissue reaction.
The Macroscopic appearance of in vivo capsules post culture are seen below.
Fig 7:4 Photos showing IBG pot harvest.
A: Capsule was first dissected off the mouse flank with the subcutaneous tissues and
skin.  B:  Sample  separated  from  mouse.  Blue  arrows  showing  microfilm  within  new
vessel formation surrounding capsule.
C: Close up photo showing blue blanching inside capsule signifying vessel penetration
into graft bed highlighted by white arrows. Scale bar: A&B 5mm C 1mm
The thickened capsule surrounding the capsules was maintained to preserve
the  fine  blood  vessels.  The  capsules  then  underwent  decalcification  as
previously described before sectioning for histology.
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7:5:2 Histology of Capsules
Fig 7:5 Microscopy views of sectioned samples following A&S staining
A: Plain Allograft sample. B: Plain Allograft and SSC. C: Collagen coated Allograft and
SSC. D: Allograft and HAp cultured SSC. Scale bars 500μm
Fig 7:6 Higher Magnification of Collagen coated sample showing small blue microfilm of
a new vessel in growth within new cellular matrix.
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Immuno histochemical staining for Col 1 was performed on all samples looking
for evidence of increased osteogenic differentiation. Unfortunately none of the
antibody  stains  would  work  and  on  discussion  with my  supervisors  it  was
thought the prolonged decalcification period may have destroyed the markers
although the Tris / EDTA used had not caused any problems with previous
experiments and immunohistochemical staining.
7:5:3 Biochemistry of subcutaneous IBG samples
Pico Green DNA assay
Five capsules from each group were immediately placed in basal culture media
on harvesting from the mice and transferred back to the lab for biochemical
assays to assess cell proliferation and osteogenic differentiation with Alkaline
Phosphatase activity.
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Fig  7:7 Pico  green  assay  of  allograft and  allograft  +  cells  as  controls  and  the
experimental groups of Collagen and HA nanoparticles. N=5. P>0.05
The above graph demonstrates no significant difference in the DNA content of
the 4 groups with fairly marked variability within the groups as signified by the
large error bars (+/-1 SD)
Alkaline  phosphatase  assays  were  also  carried  out  for  the  samples.
Unfortunately the values were negligible across all samples, with any positive
amount within the usual baseline readings for plain allograft. The results have
therefore not been included for formal analysis
7:6 Discussion
Alcian blue and Sirrus red staining reveals minimal cellular material in the plain
allograft explanted group and progressively more staining in the allograft plus
cells, type I collagen and HAp groups. Whether this represents host vascular
cells  or  culture-expanded  allogeneic  SSCs  is  unclear,  but  either  of  these
attributes would be beneficial for the IBG construct in a clinical scenario.
Furthermore, by Microfil perfusion of the circulatory system of the mouse, and
post-mortem  analysis  of  the  harvested  subcutaneous  capsule,  new  vessel
formation is demonstrated, a critical step in the tissue engineering pathway.
The  data  obtained  from  this  experiment were not  as  planned  with  the  key
biochemistry  and  immunohistochemisrty  failing  to  work.  One  of  the  main
factors for the Ab staining was thought to be secondary to the prolonged time it
took  to  get  the  samples  to  decalcify  enough  to  allow  sectioning,  despite
repeated changing of the solutions. In hindsight keeping the pseudocapsule in
place to preserve the fine vessel matrix growing into the capsule may have
prevented de mineralisation, but the initial concern was to avoid any damage
to the fine de novo vessels.143
The biochemical analysis was hampered by very variable results, and this may
well be due to the findings noted at time of surgical dissection. A few of the
capsules appeared to have little in the way of a reaction surrounding them with
little or no blood vessels, occurring in all experimental groups. In effect there
was insufficient delivery of oxygen and nutrients to the capsule in the initial
phase and we postulate that the SSC failed to proliferate.  It may also be the
case that due to the high concentration of the SSC, the metabolic demands of
some of the samples may have outstripped local supply causing subsequent
cell death.
Despite the results obtained for this experiment, the murine model used has
worked  well  in  the  past.  Bolland  et  al  has  demonstrated  that SSC  seeded
allograft implanted subcutaneously  does proliferate, and also stimulate new
blood vessel formation with significantly more and larger vessels entering the
sample compared to plain allograft. His study involved the use of SSC cultured
in osteogenic media to increase osteogenic differentiation. This is not readily
transferable to the clinical setting due to the side effects of the steroids used.
The  model  has  also  been  used  with  synthetic  scaffolds  and SSC  in
combination (Bolland et al 2008; Aarvold et al 2010) both demonstrating viable
SSC replication and osteogenic differentiation. The aim of this study was to
demonstrate that Collagen coating of the allograft, and HAp seeding of the
SSC  can  enhance  the  ongoing  osteogenic  differentiation  of  the  SSC  to
improve new bone formation.
An in vivo model is likely to increase the variability of results compared to a
controlled  in  vitro  setting.  Unfortunately  it  is  difficult  to  draw  any  strong
conclusions from the results of this experiment, with the reasons for failure
being multifactorial. Ideally the next phase of in vivo analysis will more closely
replicate the clinical setting of IBG with sufficient blood supply to support the
SSC / IBG construct.144
7:7 Conclusion
Null Hypothesis
HAp  cultured SSC  and  Collagen  coated  allograft  has  no  effect  on  the
osteogenic differentiation of SSC when cultured in an in vivo subcutaneous
mouse model
Due to the problems outlined above we have been unable to refute the null
hypothesis for this experiment.145
Section III
A  Novel  Impaction  Bone  Grafting
Technique
Chapter 8
From  Roadside  to  Revision  Hip  Surgery,  the  Role  of
Vibration Impaction in the Acetabulum
My thanks to Dr Andrew New for his assistance throughout the surgical steps
and mechanical testing146147
Chapter 8
From  Roadside  to  Revision  Hip  Surgery,  the  Role  of
Vibration Impaction in the Acetabulum
8:1 Introduction
Impaction bone grafting of fresh frozen allograft remains the gold standard for
replacing lost bone stock found during revision hip surgery. Survivorship for
acetabular  and  femoral  components  at  20  and  10  years  respectively  is
encouraging  (87%  and  99% although  such  results  have  not  always  been
repeated outside specialist centres (Eldridge et al. 1997; van Haaren et al.
2007).   It  is  however  a  technically  demanding  procedure  with  a  significant
learning  curve  and  as  such  its  use  outside  of  centres  of  excellence  is  not
widespread. Loosening of a total hip replacement can lead to a significant loss
of bone stock with only thin cortical walls left in place. The need to provide
primary  stable  fixation  of  the  revision  implant  is  critical  for  the  long  term
success  and  secondary  bony  in  growth.    This  leads  to  a  situation  where
sufficient compaction of the allograft construction is required, often requiring
high forces, imparted into a fragile host bone stock. There is therefore a thin
line between risk of fracture to the native bone and insufficient compaction of
the IBG bed.
The  compaction  of  aggregates  is  a  familiar  process  in  civil  engineering  to
provide  amongst  other  things,  roads  and  foundations.  The  mechanical
properties and ways to optimise the aggregate base have been extensively
studied (Smith GN. 2006), and these can be potentially transferred into IBG.
The aggregate should be adequately compacted and built up in layers using a
suitable  compaction  force to  enable  uniform  compaction  throughout  a  thick
layer of aggregate. The aggregate should be composed of different particle
sizes or ‘well graded’ to ensure that there are large particles to form significant
structural integrity, and smaller particles to fill the voids in between (Brewster
et al 1999, Dunlop et al 2003). The aggregate also needs to be sufficiently148
contained,  as  otherwise  sequential  impaction  will  lead  to  continued  escape
from the breach, which in clinical terms could mean an un noticed filling up of
graft into the pelvic cavity. Sufficient force also needs to be applied, and it is
this parameter that is often difficult to determine clinically.
Vibration impaction has been used in civil engineering for a long time (Smith
G.N 2006) for the successful compaction of aggregates. If vibration is used
within a confined space, certain factors have to also be considered. Inevitably
there is a fluid element to the aggregate (particularly in the setting of IBG) and
if vibration is applied in this situation a fluid pressure can build up. If there is
significant build up of fluid pressure during the vibration impaction then this can
start  to  disrupt  the  compaction  of  the  solid  aggregates  and  a  process  of
liquefaction occurs. This process can often occur during earthquakes when the
aggregate  base  below  structures  changes  into  this  liquid  state  and  the
structural supportive integrity is lost and the building appears to sink. Drainage
during vibration impaction is therefore a key factor.
Vibration impactions use as a potential surgical technique in the femur has
been studied and shown to offer significant advantages both in the compaction
of the graft and reduction in the forces required to achieve this (Bolland et al,
2008).    Acetabular  impaction  differs  from  the femur  in  that  the  defect  and
anatomy are more open and not a narrow blind ended tube, and the graft bed
can often need to be significantly thicker with large cavitatory defect caused.
The process of standard impaction also less controlled, for a femur a drop
weight is attached to the tamp to try and standardise the forces, but this is not
the case for Acetabular impaction due to the multiplanar direction of impaction
required.
8:2 Aim
The aim of this study is therefore to see if the benefits of vibration impaction
can be applied to acetabular IBG to reduce impaction forces and improve graft
compaction and cup stability149
8:3 Null Hypothesis
The use of vibration impaction in acetabular IBG does not reduce the forces
imparted to the acetabulum.
The  use  of  vibration  impaction  in  acetabular  IBG  cause  insufficient  graft
compaction and as such risks cup subsidence
8:4 Materials and Methods
8:4:1 Pelvic Model
For  the  purposes  of  this  study  and  to  obtain  reproducible  data,  sawbone
biomechanical hemi pelvis models were used (Sawbone 3
rd Generation).
The  acetabular  defects  encountered  during  revision  surgery  have  been
classified according to there morphology by Praposky. (Table 8:1)
Defect Rim Walls Columns Bone Bed
Type 1 Intact Intact Intact >50%; cancellous
Type 2 Distorted Distorted Intact <50%; cancellous
A= Superomedial
B= Superolateral
C= Isolated Medial
Type 3 Missing Severely
compromised
Non-
supportive
Membranous/
sclerotic
Table 8:1 :  Paprosky  classification  of  acetabular  defects  and  treatments  guidance.
(Paprosky, Perona et al.)150
These defects can be either contained or uncontained, but in order to proceed
with IBG the uncontained defect needs to be reconstructed for example with a
mesh.  To  avoid  unnecessary  variables  a  contained  cavitatory  defect
(Praprosky type 2a) was used for this experiment.
Using  a  custom  made  jig  (Southampton  Bioengineering  Dept)  that  allowed
multiplanar positioning of the hemipelvis, the standard anatomical acetabulum
was  reamed  using  a  set  sequence  of  reamers  to  form  a  supero  medial
cavitatory defect similar to those found in clinical practice. The volume of the
cavity was 75cm
3 with each hemipelvis prepared in identical fashion.
Figure 8:1 : Schematics  of custom jig to allow multiplanar positioning of hemipelvis
model151
Figure 8:2: Hemipelvis on Jig with reamed out cavity. Coloured sectors in cup represent
the 4 different reamers used in sequence to achieve a large, reproducible cavitatory
defect.
Stryker  Xchange  tamps  were  used  for  the  impaction  process.  These  were
modified from standard with multiple drainage holes to allow any fluid to collect
within  the  tamp  and  prevent  the  process  of  liquefaction  occurring  during
vibration impaction (Smith 1990) Fig 8:3.
The tamps were connected to a device known as the ‘Woodpecker’ (Minnesota
Bramstedt  Surgical  Inc,  St.  Paul,  MN,  USA).  It  is  a  pneumatic  hammer
designed  primarily  for  use  in  hip  replacement  surgery  for  broaching  of  the
femoral canal. Initial work by Bolland et al established the optimal pressure for
the puposes of impaction grafting as standard broaching forces were too high.
The pressure used for this experiment via a regulator waspressure regulator
was  2.4  bar  with  the  control  on  the  body  of  the  Woodpecker  set  in  the
maximum (+) position (Fig 8:3 B). The frequency of the vibrations delivered by
the Woodpecker device  were  at a  rate  of 70Hz.  The  coupling  between  the
tamp and Woodpecker was a simple sleeve that ensured the force of vibration
was transferred towards the graft bed, but on the ‘backward’ oscillation of the
device the tamp was not actively retracted by the coupling so as not to disrupt
the graft bed.152
Figure 8:3: A: Stryker Xchange tamp modified with drainage holes. B: Tamp attached to
Woodpecker  device  for  generation  of  vibrations.  Coupling  between  the  two  was  not
fixed  to  prevent  retraction  of  tamp  on  ‘backstroke’  of  vibration  impaction  and
subsequent disruption to graft base.
8:4:2 Defining Adequate Compaction
Defining  adequate  compaction  of  the  allograft  base  intra  operatively  is  a
difficult skill. In Femoral IBG this is readily defined as no further subsidence of
the tamp after 10 successive blows. In the acetabulum however this is not as
straightforward  as  the  change  in  depth  of  the  tamp  is  minimal.  In  clinical
practice, the graft base is palpated with the surgeon’s finger and the tactile
feedback  and  experience  of  the  surgeon  is  used  to  determine  when  it  is
sufficiently solid to progress on to the next layer. Experimentally this is hard to
quantatively define, it was therefore necessary to come up with a quantifiable,
and reproducible method of determining graft compaction ‘intraoperatively’.
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A device known as a penetrometer is used in engineering to determine the
compaction of aggregates such as soil. I therefore proposed that this could be
transferred to determine allograft compaction. A pen type penetrometer was
modified by reducing the tip diameter to 3.2mm diameter to allow penetration
into the graft bed without complete disruption. See Figs 8:4 & 8:6. In order to
validate the penetrometer an initial experimental run was set up to correlate
the  penetrometer  readings  to  an  experienced surgeon’s determination  of
sufficient compaction.
Fig 8:4 Modified penetrometer. a: spring loaded outer sleeve that is pushed down on
until tip of penetrometer – b penetrates the graft bed up to the second indent. c: mobile
ring from which maximal reading is taken.
8:4:3 Allograft
Allograft  used  for  this  experiment  was  prepared  in  standard  fashion  as
previously  described  in  2:1.  The  allograft  was  defrosted  and  brought  up  to
room  temperature  and  the  experiment  performed  in  a  temperature  and
humidity  controlled  laboratory.  The  volume  and  weight  of  allograft  was
standardised for all experimental runs
a b
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8:4:5 Strain Gauge
For the Experiment the hemi pelvis was mounted in the jig held with an epoxy
resin plate contoured to the sacroiliac joint and held against a small rubber
coated  metal  plate  at  the  pubis  to  represent  the  normal  anatomical
attachments of the pelvis.
A single rosette strain gauge was fitted to the medial wall of the inner pelvis to
measure the stress imparted to the wall of the pelvis (Fig 8:5). The gauge was
secured  with  cyanoacrylite  glue  (locktite  ‘Superglue’)  and covered  in  silicon
sealent to prevent damage from any water ingress. The position of the gauge
was measured and identical for each experiment.
Fig 8:5 Rosette strain gauge attached to the inner aspect of the medial acetabular wall
and covered in silicone gel to prevent fluid ingress
8:4:6 Study Design
To simplify the experimental process the IBG was divided into 6 steps for each
experimental run. A number of preliminary experimental runs were performed
to confirm the most appropriate amount of graft to be added at each step and
the impactor sequence to give a reproducible and standardised experimental
run for each group. The final sequence was as follows:
Step 1 - 50ml Graft. 46mm Impactor tamp
Step 2 - 25ml Graft. 46mm Impactor tamp
Step 3 - 25ml Graft. 46mm Impactor tamp
Step 4 – No Graft. 50mm Impactor tamp
Step 5 – 25ml Graft. 46mm Impactor tamp
Step 6 – No Graft. 50mm Impactor tamp155
To mimic the clinical phenomenon of blood pooling at the base of the IBG bed
during impaction 3ml of Fetal Calf Serum (Sigma Aldridge) was added before
steps 2 + 3. This was felt to give a similar viscocity to blood.
Strain gauge measurements were recorded throughout the six impaction steps
using a computer equipped with a data acquisition card and signal conditioning
unit (DAQCard-AI-16XE-50 and SC-2345, National Instruments Ltd, UK). Data
was sampled at a frequency of 10 kHz to ensure capture of the high frequency
components of  the  load  and  strain  signals  produced  by  the impaction. The
data was recorded using National Instruments VI Logging software.
Penetrometer readings were taken from five set zones within the acetabular
IBG  bed  to  confirm  sufficient  compaction  before  proceeding  on  to  further
addition of graft and impaction.
Fig 8:6 A: IBG graft bed with the 5 zones of penetrometer readings signified by the red
dots. B: Example of penetrometer reading with fine tip pressed into the IBG bed until
the edge was level with the second indent. Measurements were then taken from the
scale on the side
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8:4:7 Cementation
Once the final graft bed had been established, a single mix of bone cement
(Smartset CMW, DePuy CMW Ltd., Blackpool, UK),was prepared in a vacuum
mixing system (Cemvac, DePuy CMW Ltd, Blachpool, UK) as per standard
techniques. The cement was introduced into the acetabular cavity at 3 minutes
and  pressurised  in  standard  fashion  with  a  size  56  pressuriser  (Stryker,
Howmedica) for 1 minute
8:4:7 Cup Implantation
Size 48 / 28 Flanged Exeter Contemporary cups were used for all experimental
runs. The flange was cut to < 2mm rim to prevent any direct contact with the
acetabular  rim.  Although  in  normal  clinical  practice  the  flange  is  contoured
such that it rests on the acetabular rim it was felt that this would potentially
mask any small differences in the ability of the graft bed to provide structural
support during the cyclical loading. Thus as the experimental aim was to test
and differences in the graft bed and not the cup / cement / bed construct as a
whole, this was standardised for all.
To ensure standardisation of the cup positioning, the classical position of the
cup in 45Deg Adduction and 30 Deg Flexion (Exeter Hip techniques) was used
with  the  hemipelvis  orientated  on  the  jig  such  that  this  cup  position
corresponded to vertical alignment of the custom cup holder. The accuracy of
positioning was within 0.5 Degrees
To standardise the depth of the cup implantation a custom cup holder was
manufactured. This composed of a metal rod and plate with pins to locate into
the cup, and a mobile acrylic ring that could slide up and down the shaft. The
acrylic ring when placed on the ‘bony’ prominences of the acetabulum ensured
identical  alignment  of  all  cup  implantations,  with  a  marker  on  the  shaft  to
standardise the depth. See Fig 8:5157
Fig 8:5 Cup implanter. A: 1: Mobile Acrylic ring. 2: Etch mark on shaft to mark depth of
cup implantation. 3: Small prongs to engage with cup. B: 4: Mobile acrylic ring pushed
down onto bony prominences to fix angle of implantation. C: Whole jig arrangement
with cup introducer in situ 5: Shaft kept vertical to maintain constant / reproducible cup
orientation
8:4:8 Mechanical Testing
Industry standard testing parameters have been described for the testing of
Femoral  components  and  were  used  in  previous  studies  on  the  effects  of
vibration impaction in the Femur (Bolland ). Although no such standards exist
for acetabular testing the cyclical loading pattern as described by (Morlock and
Westphal et al., 2006) was deemed appropriate and used initially (Table 8:2).
Sequen
ce
Number
of
Cycles
Minimum
Load (N)
Maximum
Load (N)
Mean
Load (N)
Load
Amplitude (N)
1 20 50 200 125 75
2 980 50 800 425 375
3 1000 50 1200 625 575
4 1000 50 1600 825 775
5 47000 50 2100 1075 1025
Table 8:2 Cyclical loading protocol as per Morlock and Westphal et al.
A B C
1
2
4
3
4
5158
The maximal loading of the acetabulum occurs during heel strike. The angle of
force  during  was  calculated  in  relation  to  the  hemipelvis  model  and  the
construct re orientated on the jig such that this was in the vertical plane. An
Instron  8878  servo-hydraulic  materials  testing  machine  (Instron  Ltd,  High
Wycombe, UK) was used to  load the test rig cyclically. This was achieved via
attacement of a standard 28mm V40 Exeter Stainless Steel Femoral head to
the Instrom which was then lowered into the cup and the whole construct fixed
in place. Axial displacement / Subsidence of the cup was measured directly
from the Instron transducer.
Fig 8:6 A: Hemi Pelvis repositioned under Instron actuator with 28mm V40 Head lowered
into socket. B: Close up of Pelvic orientation and V40 Head engaged in socket.
During the first two experimental runs it became apparent that the sawbone
model used was unable to tolerate the forces applied for the final maximal load
run of 47,000 cycles at 2100N. Cracks started to appear at a stress riser just
proximal to the ‘Sacral’ attachment of the model.
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Fig 8:7 A: Hemi Pelvis model post cyclical testing showing fracture propagation across
Iliac wing highlighted by arrows.
As the aim of the experiment was to assess graft stability under load and not
the  ultimate  failure  of  the  Sawbone  hemipelvis  models,  the  original  cyclical
loading protocol was modified with a final run of 48,000 cycles at a maximum
load of 1600N. As this was still well within the physiological loads experienced
during the normal  gait cycle,  therefore  replicating  the  appropriate  loads
encountered  in  the  clinical  setting  of  revision  THRs.  No  further  failures
occurred at this new loading protocol.
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Sequence
Number of
Cycles
Minimum
Load (N)
Maximum
Load (N)
Mean
Load (N)
Load
Amplitude
(N)
1 20 50 200 125 75
2 980 50 800 425 375
3 1000 50 1200 625 575
4 48,000 50 1600 825 775
Table 8:3 New loading protocol following two failures in sawbone models
at sacral attachment
8:4:9 Torque Failure test
Once the hemi pelvis model had undergone the cyclical loading testing and
cup subsidence measured the final test was intended to assess the ultimate
torque failure of the construct. This was again done via the instron machine
with the acetabular cup attached to it via two pins located within the standard
cup  introducer  holes  within  the  polyethylene.  Under  a  compressive  load  of
700N a rotational shear force was then applied to the cup at a rate of 0.5
o / sec
and the force at which the bone / graft / cement interface failed was measured.
As  these  were  Left  hemipelvis  models  the  actuator  was  rotated  in  an
anticlockwise direction.
Although pre programmed stop points were made to try and prevent excessive
rotation, the margin between point of failure of the construct and fracture of the
acetabular  rim  was  found  to  be  very  small.  This  resulted  in  the  first  two
samples  fracturing  (Fig  8:8),  so  due  to  the  constraints  of  numbers  of
hemipelvis models available this section of the experiment was not continued.161
Fig 8:8 Acetabular wall fracture post tortional failure test A: In jig with coupling between
cup and Instron. B: Close up of fracture line highlighted by arrows
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8.5 Results
8:5:1 Validation of Penetrometer
An  experienced  surgeon  (DGD)  was  analysed  for  12  impaction  steps  with
Penetrometer  readings  taken  at  each  step  corresponding  to  the  5  arbitrary
zones of the graft bed (Superior 1 + 2, Medial, Pubis and Ischium See Fig 8:6).
The surgeon’s comment as to whether the graft was sufficiently or insufficiently
compacted  at  each  zone  was  noted  and  the  corresponding  penetrometer
reading taken.
Surgeons
assessment
Corresponding Penetrometer reading
(proportional to N/m
2)
Mean value +/ - SD
Insufficiently
compacted
2.31 +/- 0.66 (Range 1 - 3)
Sufficiently
compacted
3.67 +/- 0.52 (Range 3 - 4.75)
Table 8:4 Mean penetrometer readings from all 5 zones over 12 impactions linked with
surgeon’s assessment of graft stability.
From  this  initial experimental  run  it became  apparent  that  a  penetrometer
reading  of  3.0  was  the  arbitrary  transition  zone  between  what  the  surgeon
considered insufficient to sufficiently compacted. In order to prevent any false
positives it was decided that a reading of greater than 3.5 should be used to
ensure sufficient compaction of all 5 areas of the graft bed at the end of the
impaction process.163
8:5:2 Penetrometer, Graft Weight and Subsidence Results
As  described above,  penetrometer  readings  were  taken  throughout  the
impaction process. If insufficient compaction was achieved, further graft and
impaction was directed to that zone. The following table (8:5) shows the mean
penetrometer readings at the end of the impaction process in the two groups.
Standard Impaction
Mean +/- SD
Vibration Impaction
Mean +/- SD
Penetrometer
readings
3.75 +/- 0.15 3.78 +/- 0.20
Table 8:5 Mean penetrometer readings after final impaction in control and experimental
groups. p > 0.05.
The allograft used was measured both in volume, as described in the methods,
and  also  the  total  weight  used  for  each  experimental  run.  The  table  below
shows the mean weight of both control and vibration groups with no significant
difference between the two
Standard Impaction
Mean +/- SD
Vibration Impaction
Mean +/- SD
Weight of
Allograft used
(g).
60.1 +/- 5.20 63.6 +/- 5.2
Table 8:6 Mean weight of allograft used for each experimental run. p > 0.05
The subsidence of the cup post cyclical loading is one of the key factors as it is
one of the main determinates for long term survival of the construct. The table
below shows the amount of subsidence in the direction of the cyclical loading
force  (superomedial).  There  was  no  significant  difference  between  the  two
groups (p > 0.05)
.164
Standard Impaction
Mean +/- SD
Vibration Impaction
Mean +/- SD
Cup subsidence
post cyclical
testing
2.97 +/- 0.49 3.00 +/- 0.53
Table 8:7 Mean Cup subsidence post cyclical loading. p > 0.05
8:5:3 Peak stress measurements
The Graph in Fig 8:9 represents the stress imparted to the medial wall of the
acetabulum for both standard control group and the Vibration group.
It shows the mean of the absolute peak stresses during impaction, and it is
these maximal spikes of stress than can potentially lead to sudden fracture. It
can  be  observed  that  as  the  graft  bed  builds  up  in  the  acetabulum  so  the
stress imparted to the medial wall reduces, signified by the down sloping of the
trend line. This was most marked for the standard impaction group with the
vibration group giving a more linear level of stress.
The absolute maximal mean peak stress for the control group during step 1
was 110.82 (SD 17.3) MPa compared to 34.66 (SD 6.3)MPa for the Vibration
group which was significantly reduced (p=0.03). There was also a significant
(p<0.05) reduction for steps 3,4 and 5 as well, with step 2 p=0.06.165
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Fig  8:9 Mean  Peak  Stress  (MPa)  for  Standard  and  Vibration  impaction  over  the  six
impaction  steps  showing  significantly  less  Stress  in  the  Vibration  impaction  group
(Red).
8:5:4 Complications
One medial  wall  fracture  (Fig  8:10) occurred  during  the  standard  impaction
process.  No  fractures  were  observed  for  the  vibration  impaction  group.  As
previously mentioned 4 other fractures occurred during preliminary testing, but
none of these were related to the actual IBG technique.166
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Fig  8:10 Hairline  fracture  through  medial  wall  of  acetabulum  following  standard
impaction bone grafting
8:6 Discussion
The  aim  of  this  study  was  to  assess  the  effect  of  vibration  impaction  and
drainage compared to the current gold standard of IBG. Great care has been
taken  to  try  and  eliminate  as  many  of  the  main  cofounding  variables  as
possible such that Impaction forces and cup stability after cyclical loading are
the two main outcome variables. All cups were implanted in the same position
with no significant difference in the amount of graft used or the degree of graft
compaction achieved as measured with the penetrometer.
Impaction  bone  grafting  can  be  a  difficult  surgical  skill  with  a  significant
learning  curve.  There  a  fine  line  between  insufficient  impaction  and
subsequent implant failure, and excessive impaction force leading to fracture
and  subsequent  complications.  Previous  published  studies  have  shown
subsidence rates of between 5 and 25% (Eldridge et al. 1997). In those studies
with higher failure rates, one factor could be insufficient compaction of the graft
base due to concern about intraoperative fracture.
Whilst  there  is  no  substitute  for  the  assessment  and  tactile  feedback  that
experience  brings  when  determining  sufficient  compaction  the  use  of  the167
penetrometer in this situation has potential clinical application. Throughout the
multiple experiments and impactions the readings compared to an experienced
surgeon’s assessment of graft compaction were very consistent.  Whilst further
calibration  and  optimisation  of  the  design  may  be  required,  this  pilot  study
showed potential clinical translation. This may therefore be a useful tool during
the initial learning curve of an inexperienced surgeon to avoid insufficient graft
compaction and subsequent massive subsidence / failure.
As the graft bed builds up the native bone is obscured from the surgeons view
and hairline or non catastrophic fractures caused intraoperatively may not be
noticed until the case is finished, either on post op xrays or on failure during
mobilisation.  This  study  has  demonstrated  that  vibration  assisted  impaction
significantly reduces  the  peak stress  imparted  to  the  acetabular  floor  thus
reducing the risk of fracture whilst still achieving good graft compaction and
implant stability. Despite significant reduction in the peak forces imparted to
the medial wall, there was no significant difference in the subsidence after
 It  has  also  demonstrated  that  vibration  impaction  gives  a  much  more
controlled and consistent force as demonstrated by the significantly reduced
variability in the peak stresses compared to the standard group.
Although the surgical technique and physiological forces involved in femoral
and acetabular IBG are very different, this study has found similar benefits to
the  use  of  vibration  impaction  (Bolland  et  al  2007).  In the  Femoral
experimental model not only were the impaction forces significantly reduced,
but  vibration  impaction  also  lead  to  greater  graft  compaction  and  implant
stability compared to standard impaction.
Subsequent  to  this  study  other  groups  have  also  analysed  the  effects  of
vibration  impaction  in  acetabular  IBG.  In  a  study  by  Putzer,  they  used  a
simplified plastic acetabular cup to compare the difference in the allograft bed
(Putzer  D  et  al  2011).  The  variables  studied  were  the  impaction  hardness,
penetration resistance, contact stiffness and bulk density. 30g of allograft chips
were  used for  each  experiment.  Maximal forces  for  the  standard  IBG  were168
369N  and  308N  for  the  vibration  impaction.  They  demonstrated  significant
improvement  in  all  the  measured  parameters  for  the  VIBG  group  with  the
differences increasing with the duration of impaction. Whilst no attempt has
been made to test the graft bed in the presence of a cemented cup or stability
following  cyclical  testing,  these  results  further  support  the  use  of  VIBG  for
impaction grafting
Another study looking at acetabular IBG techniques by Brennan has also just
been published (Brenan et al 2011). Again, using a simplified in vivo model
and  bovine  allograft  this  study  analysed  primarily  the  effect  of  impaction
technique  on  the  graft  beds  shear  strength and  the  effect  of  vibration
frequency. The study was performed in two phases the first with a dry graft
bed, and the second with a ‘wet’ bed with introduction of bovine blood during
the impaction to reproduce the effect of back bleeding experienced clinically.
They found that in the dry state vibration impaction improved the graft beds
shear strength compared to standard impaction with increasing increments up
to  the  maximum  studied  at  60Hz  (Shear  strength  342kPa  vs  319kPa  for
standard impaction).  In the ‘wet’ phase of the study there was no significant
difference between 60Hz vibration and standard impaction. They suggest that
as  the  saturated  graft  is  more  representative  of  the  clinical  scenario  that
vibration impaction is not beneficial to the IBG process due to the phenomenon
of liquefaction causing disruption of the graft bed with the fluid pressure waves.
As  discussed  earlier  liquefaction  is  a  significant  consideration,  and  for  the
purposes  of  our  study  care  was  taken  to  replicate  back  bleeding  with  the
addition  of  FCS,  but  to  counteract  the  problem  of  fluid  pressure  waves
disrupting the graft the impactor tamps were modified to allow drainage of the
fluid.  The  fact  that  no  liquefaction  occurred  during  the  vibration  impaction
phases despite significant graft saturation and that good implant stability was
observed with extended cyclical testing suggests that this modification of the
tamps is indeed a key part of the set up if the true benefits of VIBG are to be
observed.
Whilst some of the early work by Bolland looked into the optimal pneumatic
pressures for the woodpecker device for use in VIBG, no formal analysis of the
vibration frequency  was  studied.  The  Woodpecker  device  has  a  standard169
oscillating frequency of 70Hz, and as 60Hz was the maximal frequency used
by Brenan et al it is difficult to know what the optimal frequency is and further
experiments are required to define this. Whilst Brenan et al conclude that VIBG
is not beneficial their results may have been significantly different if drainage of
the tamp was undertaken, so to date the combination of these 3 acetabular
and 1 femoral in vitro studies all point to a significant beneficial effect of VIBG
and  drainage  in  reducing  the  peak  forces  in  IBG  and  improving  implant
stability.
8:7 Summary
I propose that the application of vibration IBG coupled with drainage for the
IBG  process  in  the  acetabulum  can  significantly  reduce  the  risk  of
intraoperative  fracture  whilst  achieving  good  graft  compaction  and  implant
stability.  Given  the  observed  reproducibility  of  this  new  approach,  with
significantly  less  variability;  vibration  IBG  offers  improved  ‘safety  margins’
within the IBG process. This new approach offers the potential to reduce the
learning curve for surgeons and thus offers the potential for increased adoption
of the technique for replacing lost bone stock.
8:8Conclusion
Null Hypothesis
The use of vibration impaction in acetabular IBG does not reduce the forces
imparted to the acetabulum.
This has been shown to be False
The  use  of  vibration  impaction  in  acetabular  IBG  cause  insufficient  graft
compaction and as such risks cup subsidence
This has shown to be False170171
Chapter 9
Summary and Future Direction
9:1 Summary
The experiments carried out as part of this thesis along with the translation into
clinical  cases  have  allowed  us  to  refute  the  Major  Null  Hypothesis.
Manipulation  of  the SSC  with  extracellular  membrane  proteins  and
Hydroxyapatite  have  indeed  enhanced  the  IBG’s  biomechanical  properties,
and this if used in combination with increased SSC concentration and lower
impaction  forces  with  vibration  impaction  should  have  synergistic  effect  to
promote  the  formation  of  a  new  living  bony  construct  able  to  support  the
prosthesis and host skeleton.
The conclusion from the experiments carried out in this thesis are summarised
below:
The  Effect  of  Skeletal  Stem  Cell  Concentration  on  the  Biomechanical
Properties of Impacted Bone Graft
Following on from the seminal work by Hernigou et al on fracture non union,
and preliminary studies by Tilley and Bolland on the survival and effects of
SSC in IBG, this study has shown that the concentration of SSCs seeded on to
IBG has a critical effect on its biomechanical properties. Failure under shear of
the IBG graft bed can lead to catastrophic subsidence of the prosthesis as has
been shown in a number of clinical studies with high failure rates (Eldridge et
al  1997;  van  Haaren  et  al  2007). The  use  of  a  concentrated SSC  fraction
seeded on to the IBG therefore has the potential to improve the shear strength
in  vivo  and  reduce  this  risk  of  subsidence.  From  this  in  vitro  study  the
concentration is above 5 x 10
4 cells per cc of allograft which is greater than the
usual  concentration  found  in  bone  marrow  aspirate  (Hernigou  et  al  2005).
Further work on the optimal in vivo concentration is required and how best to
achieve  that  concentration  either  by  culture  expansion  or  cell  fraction
separation is required.172
Clinical  Translation  of  Enriched  Skeletal  Stem  Cells  and  IBG  in  the
treatment of AVN and Fracture Non Union
The translation of the findings of SSC concentration and IBG into the treatment
of clinical cases of AVN and fracture non union has shown encouraging early
results. The parallel in vitro culture of the SSC and graft used for the clinical
cases  has  also  enabled  detailed  analysis  of  the  biochemical  and  cellular
changes  occurring,  demonstrating  a  significantly  higher  CFU-F  yield  and
increased cellular and matrix proliferation across the allograft. Whilst there has
been one failure of the AVN cases, in retrospective analysis the case may
have  deteriorated  further  than  first  thought  at  the  time  of  treatment.
Encouragingly ex vivo analysis of the retrieved femoral head has shown good
structural support in the treated area with full integration of the IBG channel
and normal restoration of the trabecular pattern (Aarvold et al 2010).
The Biomechanical Effect of Type I Collagen on SSC seeded IBG
This study has demonstrated than coating of the allograft granules with a layer
of Type I Collagen significantly improves the Osteogenic differentiation of SSC
seeded on to the scaffold potentially leading to improved new bone formation.
We  have  also  demonstrated  that  following  in  vitro  culture  this  leads  to
significantly improved shear strength of the construct.
The Use of Hydroxyapatite Nanoparticles to Enhance the Biomechanical
Properties of IBG
Hydroxyapatite  is  used  extensively  in  Orthopaedic  surgery  primarily  as  a
surface  coating.  This  study  has  shown  that  when  used  in  crystalline
nanoparticle form it has the ability to be taken up by the SSC cells in culture
and leads to significantly improved osteogenic differentiation. This study has
furthered the work by Babister et al by showing that this enhanced osteogenic
differentiation can improve the mechanical properties of IBG when cultured in
vitro leading to significantly improved shear strength of the construct.173
Murine  in  vivo  Analysis  of  the  Biological  Effects  of  Type  1  Collagen
Coated IBG and HAp Cultured SSC
This study used a subcutaneous murine model to analyse the in vivo effects of
SSC,  Type  I  Collagen  and  HAp  cultured SSC.  The  study  has  shown  new
vessel  formation  around  the  capsule  and  growth  into  the  IBG  construct.
Samples  with SSC  also  showed  increased  cellular  and  matrix  production
between the allograft chips. There was however no demonstrable difference in
the Alkaline Phospahatase activity and DNA content on biochemical assays
and  due  to  technical  failures  in  the  decalcification  process  further
immunohistochemical analysis was not possible.
The Use of Vibration Impaction Bone Grafting as a Novel Technique in
IBG
This  study,  following  on  from  the  work  by  Bolland  et  al  on  the  Femur  has
assessed  the  effects  of  vibration  impaction  and  drainage  on  an  acetabular
model  of  IBG. I have  demonstrated  that  vibration  impaction  significantly
reduces  the  peak  stresses  imparted  to  the  fragile  pelvis  during  IBG  thus
reducing the risk of peri-operative fracture. Despite the reduction in forces, a
statistically similar level of graft compaction was achieved with no increase in
the subsidence of the revision acetabular construct after physiological loading
through  50,000  cycles. I have  also  modified  a  device known  as  a
penetrometer, used in civil engineering to aid in the intra-operative assessment
of graft compaction to quantify an appropriate end point and potentially aid the
inexperienced surgeon.174175
9:2 Future Directions
The use of Skeletal Stem Cells in the treatment of musculoskeletal conditions
is potentially the next big step change in Orthopaedics in the coming years.
Novel ways to manipulate SSC down the appropriate stromal lineage are key
factors to enable reliable, tissue specific therapies for bone or cartilage loss for
example.
One  of  the  key  factors  in  enabling  transfer  of  these  strategies  into  clinical
practice, particularly in the NHS is by reducing the complexity and cost of the
process whilst still maintaining the beneficial outcome. Following on from my
work in this thesis on the effects of SSC concentration on the biomechanical
properties, our group has been collaborating with a major orthopaedic industry
company  designing  and  testing  a  new  bone  marrow  aspirate  concentrating
system. This novel technology has won a number of awards to date and has
the  potential  to  offer  a  simple,  cheap disposable device  to  allow  significant
SSC  concentration  within  the  sterile  field  of  the  operating  theatre.  This
therefore has the potential to do away with the logistical and cost implications
of  distant SSC  culture  expansion  as  well  as  reducing  the  potential  risk  of
contamination.
The work in this study has been with both culture expanded and centrifuge
concentrated  fractions  of SSC  both  from  bone  marrow aspirate.  No  direct
comparison has been made on the biomechanical outcomes between these
two  methods.  Clarke  showed  that  in  an  ulna  defect  model,  bone  marrow
aspirate  gave  increased  new  bone  formation  than  culture  expanded  cells
(Clarke  et  al  2007).  As  discussed  above  there  are  many  advantages  and
disadvantages  of  both methods  and  further  study  into  the potential
biomechanical differences are required. More recent interest has been looking
for  other  potential  sources  of SSC for  use  in  the  treatment  of fracture  non
union (Niemeyer et al 2010; Monaco et al 2011) in particular Adipose.derived
Stem Cells (ASC). The potential benefits being a more abundant source with
less  donor  site  morbidity,  more  extensive  in  vivo  analysis  in  this  area  is176
required. Although there is no one surface antigen specific to the true Skeletal
Stem Cell subset of the stromal cell lineage further ‘purification’ of samples can
be achieved by flow cytometry or magnetic activated cell separation (MACS).
Again  no  study  has  looked  at  whether these  specific  sub  sections  of  the
stromal cell population in the BMA confer any potential clinical biomechanical
benefit.
This thesis has demonstrated the benefit of both the addition of SSC to the
graft and also the reduced forces imparted by vibration impaction. It is possible
that combination of these two methods would lead to less cell death due to
physical disruption during the IBG process therefore leading to increased live
cell concentration on the graft with enhanced biomechanical characteristics.
Further study with modification of the above methods is required.
Whilst the murine model used for this study enables analysis of the samples in
vivo it is clearly not a true representation of the biological conditions that IBG in
the setting of revision arthroplasty is under as no load was applied following
containment  within  the  capsules..  Further  work  on  larger  animal  models  is
required to analyse the true effects of SSC and IBG under physiological loads
within a true bony cavity. A suitable sheep model has been designed for this
with appropriate scaled hip hemiarthroplasty models. The true in vivo benefits
of SSC concentration and extracellular matrix proteins can be analysed.
Hydroxyapatite has been used widely in orthopaedics for many years (Furlong
et al 1991), but predominantly as a surface coating. The in vitro results of the
HAp  nanoparticles  are  very  encouraging,  but  clearly  before  this  can  be
translated into clinical practice, further work on the in vivo effects are required.
Studies to assess the local rate of bone formation and cessation of formation,
and  on  any  potential  side  effects  either  at  a  cellular  level  locally  and  on
potential distant spread to other tissues would need to be performed. Whilst I
have demonstrated uptake into the cells with and excess of the nanoparticles
removed during the washing process, further work to exclude any  potential
mechanical problems of bearing surface wear are required.177
Fig 9:1 Cultured SSC on Allograft Scaffold178179
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